Cervical cancer

Each year, more than half a million women are diagnosed with cervical cancer and the disease results in over 300 000 deaths worldwide. High-risk subtypes of the human papilloma virus (HPV) are the cause of the disease in most cases. The disease is largely preventable. Approximately 90% of cervical c...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The Lancet (British edition) Ročník 393; číslo 10167; s. 169 - 182
Hlavní autori:	Cohen, Paul A, Jhingran, Anjua, Oaknin, Ana, Denny, Lynette
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Elsevier Ltd 12.01.2019 Elsevier Limited
Predmet:	Bevacizumab Cancer Cervical cancer Cervix Chemoradiotherapy Female Fertility Global Health Health risk assessment Healthcare Disparities - statistics & numerical data HIV Human immunodeficiency virus Human papillomavirus Humans Hysterectomy Immunotherapy Incidence Income Mass Screening - methods Mass Screening - statistics & numerical data Metastases Monoclonal antibodies Mortality Neoplasm Staging Papillomavirus Infections - epidemiology Papillomavirus Vaccines - immunology Poverty Radiation therapy Risk Factors Screening Solid tumors Targeted cancer therapy Toxicity Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - therapy Vaccination Vaccines Vascular endothelial growth factor Viruses Womens health United States > US South Africa Africa
ISSN:	0140-6736, 1474-547X, 1474-547X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Each year, more than half a million women are diagnosed with cervical cancer and the disease results in over 300 000 deaths worldwide. High-risk subtypes of the human papilloma virus (HPV) are the cause of the disease in most cases. The disease is largely preventable. Approximately 90% of cervical cancers occur in low-income and middle-income countries that lack organised screening and HPV vaccination programmes. In high-income countries, cervical cancer incidence and mortality have more than halved over the past 30 years since the introduction of formal screening programmes. Treatment depends on disease extent at diagnosis and locally available resources, and might involve radical hysterectomy or chemoradiation, or a combination of both. Conservative, fertility-preserving surgical procedures have become standard of care for women with low-risk, early-stage disease. Advances in radiotherapy technology, such as intensity-modulated radiotherapy, have resulted in less treatment-related toxicity for women with locally-advanced disease. For women with metastatic or recurrent disease, the overall prognosis remains poor; nevertheless, the incorporation of the anti-VEGF agent bevacizumab has been able to extend overall survival beyond 12 months. Preliminary results of novel immunotherapeutic approaches, similarly to other solid tumours, have shown promising results so far.
AbstractList	Each year, more than half a million women are diagnosed with cervical cancer and the disease results in over 300 000 deaths worldwide. High-risk subtypes of the human papilloma virus (HPV) are the cause of the disease in most cases. The disease is largely preventable. Approximately 90% of cervical cancers occur in low-income and middle-income countries that lack organised screening and HPV vaccination programmes. In high-income countries, cervical cancer incidence and mortality have more than halved over the past 30 years since the introduction of formal screening programmes. Treatment depends on disease extent at diagnosis and locally available resources, and might involve radical hysterectomy or chemoradiation, or a combination of both. Conservative, fertility-preserving surgical procedures have become standard of care for women with low-risk, early-stage disease. Advances in radiotherapy technology, such as intensity-modulated radiotherapy, have resulted in less treatment-related toxicity for women with locally-advanced disease. For women with metastatic or recurrent disease, the overall prognosis remains poor; nevertheless, the incorporation of the anti-VEGF agent bevacizumab has been able to extend overall survival beyond 12 months. Preliminary results of novel immunotherapeutic approaches, similarly to other solid tumours, have shown promising results so far. Summary Each year, more than half a million women are diagnosed with cervical cancer and the disease results in over 300 000 deaths worldwide. High-risk subtypes of the human papilloma virus (HPV) are the cause of the disease in most cases. The disease is largely preventable. Approximately 90% of cervical cancers occur in low-income and middle-income countries that lack organised screening and HPV vaccination programmes. In high-income countries, cervical cancer incidence and mortality have more than halved over the past 30 years since the introduction of formal screening programmes. Treatment depends on disease extent at diagnosis and locally available resources, and might involve radical hysterectomy or chemoradiation, or a combination of both. Conservative, fertility-preserving surgical procedures have become standard of care for women with low-risk, early-stage disease. Advances in radiotherapy technology, such as intensity-modulated radiotherapy, have resulted in less treatment-related toxicity for women with locally-advanced disease. For women with metastatic or recurrent disease, the overall prognosis remains poor; nevertheless, the incorporation of the anti-VEGF agent bevacizumab has been able to extend overall survival beyond 12 months. Preliminary results of novel immunotherapeutic approaches, similarly to other solid tumours, have shown promising results so far. Each year, more than half a million women are diagnosed with cervical cancer and the disease results in over 300 000 deaths worldwide. High-risk subtypes of the human papilloma virus (HPV) are the cause of the disease in most cases. The disease is largely preventable. Approximately 90% of cervical cancers occur in low-income and middle-income countries that lack organised screening and HPV vaccination programmes. In high-income countries, cervical cancer incidence and mortality have more than halved over the past 30 years since the introduction of formal screening programmes. Treatment depends on disease extent at diagnosis and locally available resources, and might involve radical hysterectomy or chemoradiation, or a combination of both. Conservative, fertility-preserving surgical procedures have become standard of care for women with low-risk, early-stage disease. Advances in radiotherapy technology, such as intensity-modulated radiotherapy, have resulted in less treatment-related toxicity for women with locally-advanced disease. For women with metastatic or recurrent disease, the overall prognosis remains poor; nevertheless, the incorporation of the anti-VEGF agent bevacizumab has been able to extend overall survival beyond 12 months. Preliminary results of novel immunotherapeutic approaches, similarly to other solid tumours, have shown promising results so far.Each year, more than half a million women are diagnosed with cervical cancer and the disease results in over 300 000 deaths worldwide. High-risk subtypes of the human papilloma virus (HPV) are the cause of the disease in most cases. The disease is largely preventable. Approximately 90% of cervical cancers occur in low-income and middle-income countries that lack organised screening and HPV vaccination programmes. In high-income countries, cervical cancer incidence and mortality have more than halved over the past 30 years since the introduction of formal screening programmes. Treatment depends on disease extent at diagnosis and locally available resources, and might involve radical hysterectomy or chemoradiation, or a combination of both. Conservative, fertility-preserving surgical procedures have become standard of care for women with low-risk, early-stage disease. Advances in radiotherapy technology, such as intensity-modulated radiotherapy, have resulted in less treatment-related toxicity for women with locally-advanced disease. For women with metastatic or recurrent disease, the overall prognosis remains poor; nevertheless, the incorporation of the anti-VEGF agent bevacizumab has been able to extend overall survival beyond 12 months. Preliminary results of novel immunotherapeutic approaches, similarly to other solid tumours, have shown promising results so far.
Author	Denny, Lynette Cohen, Paul A Oaknin, Ana Jhingran, Anjua
Author_xml	– sequence: 1 givenname: Paul A surname: Cohen fullname: Cohen, Paul A email: paul.cohen@uwa.edu.au organization: Department of Gynaecological Oncology, Bendat Family Comprehensive Cancer Centre, St John of God Subiaco Hospital, Subiaco, Western Australia, WA, Australia – sequence: 2 givenname: Anjua surname: Jhingran fullname: Jhingran, Anjua organization: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, TX, USA – sequence: 3 givenname: Ana surname: Oaknin fullname: Oaknin, Ana organization: Medical Oncology Department, Gynaecological Tumour Unit, Vall d'Hebron University Hospital, Vall d'Hebron, Institute of Oncology (VHIO), Barcelona, Spain – sequence: 4 givenname: Lynette surname: Denny fullname: Denny, Lynette organization: Department Obstetrics and Gynaecology, University of Cape Town, Cape Town, South Africa
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/30638582$$D View this record in MEDLINE/PubMed
BookMark	eNqNkU1LAzEQhoMo2qr4CxTBix5WJ9lssouISPELBA8q9BbS2VlI3e7WZFvovze16qEXPU0Oz_sy86TPNpu2IcYOOZxz4OriBbiEROlUnfL8LBVSQzLcYD0utUwyqYebrPeL7LB-CGMAkAqybbaTgkrzLBc9djAgP3do62O0DZLfY1uVrQPtf89d9nZ3-zp4SJ6e7x8HN08JSqm7pEI-Ak2FzhFKQi2FQlFZLosSi0KmstSqLIUmW_D4ACmQdMWzEUieC8B0l52ueqe-_ZhR6MzEBaS6tg21s2AE18XyKJFH9GQNHbcz38TtIqUUFACFiNTRNzUbTag0U-8m1i_Mz6kRyFYA-jYET9UvwsEslZovpWbpy_DcfCk1w5i7XMuh62zn2qbz1tV_pq9XaYoy5468Cegomi6dJ-xM2bo_G67WGrB2zfLL3mnxj_wnl0CfjA
CitedBy_id	crossref_primary_10_1016_j_apradiso_2023_110792 crossref_primary_10_1038_s41598_024_74399_0 crossref_primary_10_1002_ijgo_14429 crossref_primary_10_1007_s10508_023_02736_x crossref_primary_10_1016_j_canlet_2022_215838 crossref_primary_10_1038_s41419_020_02826_x crossref_primary_10_3389_fnut_2023_1113588 crossref_primary_10_1007_s00280_024_04747_4 crossref_primary_10_1002_mc_23294 crossref_primary_10_1371_journal_pone_0295632 crossref_primary_10_1016_j_artmed_2023_102756 crossref_primary_10_1016_j_biomaterials_2023_122452 crossref_primary_10_1080_03007995_2023_2178081 crossref_primary_10_1186_s12879_024_10011_0 crossref_primary_10_3390_vaccines8020181 crossref_primary_10_4103_ayu_ayu_318_21 crossref_primary_10_3390_jcm13010027 crossref_primary_10_1002_cnr2_1514 crossref_primary_10_1007_s10389_025_02524_y crossref_primary_10_1002_ijgo_70366 crossref_primary_10_1016_j_canep_2023_102355 crossref_primary_10_1016_j_fitote_2024_106323 crossref_primary_10_2217_fon_2021_0529 crossref_primary_10_1136_ijgc_2021_002473 crossref_primary_10_1186_s12645_022_00134_x crossref_primary_10_1016_j_prp_2024_155125 crossref_primary_10_1007_s00432_023_05578_1 crossref_primary_10_1002_prot_26226 crossref_primary_10_1097_MD_0000000000033597 crossref_primary_10_1136_ijgc_2021_002491 crossref_primary_10_1186_s12889_024_19881_0 crossref_primary_10_1002_prp2_1016 crossref_primary_10_3389_fonc_2023_1143691 crossref_primary_10_25259_Cytojournal_225_2024 crossref_primary_10_1055_s_0042_1743262 crossref_primary_10_1007_s00521_023_08757_w crossref_primary_10_1016_j_critrevonc_2020_103192 crossref_primary_10_1016_j_bcp_2021_114891 crossref_primary_10_1186_s13104_025_07275_3 crossref_primary_10_1016_j_canep_2024_102641 crossref_primary_10_1186_s13027_020_0272_3 crossref_primary_10_1038_s41419_022_05501_5 crossref_primary_10_1007_s10616_024_00694_3 crossref_primary_10_1016_j_ejso_2022_02_018 crossref_primary_10_1007_s12032_025_02700_w crossref_primary_10_1007_s12032_022_01942_2 crossref_primary_10_1245_s10434_020_09016_1 crossref_primary_10_3390_cancers12061472 crossref_primary_10_1038_s41597_024_03596_3 crossref_primary_10_3390_jcm14113817 crossref_primary_10_3390_ijms222111971 crossref_primary_10_3390_ijms251910604 crossref_primary_10_1016_j_gene_2024_148518 crossref_primary_10_1038_s41598_023_37346_z crossref_primary_10_1007_s13577_021_00493_4 crossref_primary_10_1016_j_artmed_2023_102536 crossref_primary_10_1186_s12985_023_02125_9 crossref_primary_10_31083_j_ceog5003057 crossref_primary_10_1016_j_arabjc_2021_103684 crossref_primary_10_1016_j_bspc_2023_105501 crossref_primary_10_1097_MD_0000000000042280 crossref_primary_10_1186_s12885_023_11639_y crossref_primary_10_3390_cancers15072042 crossref_primary_10_1016_j_prp_2024_155574 crossref_primary_10_1007_s00520_023_07790_8 crossref_primary_10_1007_s44163_024_00185_6 crossref_primary_10_1186_s12935_025_03786_y crossref_primary_10_1016_j_jcis_2021_11_019 crossref_primary_10_1097_COC_0000000000000629 crossref_primary_10_1080_21655979_2021_1890377 crossref_primary_10_1001_jamanetworkopen_2025_0033 crossref_primary_10_1016_j_bpj_2024_05_014 crossref_primary_10_3390_ijms23010333 crossref_primary_10_1177_09731296231204132 crossref_primary_10_1097_JS9_0000000000001956 crossref_primary_10_1002_jbt_22749 crossref_primary_10_1212_WNL_0000000000208059 crossref_primary_10_3389_fgene_2022_837343 crossref_primary_10_1371_journal_pone_0271679 crossref_primary_10_2174_0929867330666230112165503 crossref_primary_10_1007_s12013_025_01813_3 crossref_primary_10_1128_jcm_01352_24 crossref_primary_10_1177_18758592251341157 crossref_primary_10_1111_jog_15411 crossref_primary_10_3389_fcell_2021_637400 crossref_primary_10_3390_pathogens12020298 crossref_primary_10_1007_s12032_024_02462_x crossref_primary_10_1016_j_critrevonc_2020_103178 crossref_primary_10_3389_fgene_2021_653051 crossref_primary_10_3389_fgene_2022_938250 crossref_primary_10_1016_j_jogoh_2024_102757 crossref_primary_10_7748_phc_2023_e1803 crossref_primary_10_1186_s12905_021_01402_5 crossref_primary_10_1080_0284186X_2023_2245557 crossref_primary_10_1016_j_molstruc_2025_141569 crossref_primary_10_3389_fmed_2023_1161835 crossref_primary_10_1177_1535370220959747 crossref_primary_10_3390_medicina59020358 crossref_primary_10_1016_j_critrevonc_2022_103704 crossref_primary_10_1016_j_rechem_2025_102330 crossref_primary_10_1021_acs_analchem_5c00280 crossref_primary_10_1038_s41419_021_04193_7 crossref_primary_10_1155_2022_7016079 crossref_primary_10_1007_s10585_025_10330_9 crossref_primary_10_7759_cureus_39035 crossref_primary_10_3390_medicina60101585 crossref_primary_10_1002_adhm_202300563 crossref_primary_10_1080_16583655_2021_1991732 crossref_primary_10_3389_fpubh_2023_1205170 crossref_primary_10_1002_path_6290 crossref_primary_10_3389_fonc_2023_1190251 crossref_primary_10_1200_GO_20_00153 crossref_primary_10_1016_j_bios_2023_115483 crossref_primary_10_1016_j_virol_2024_110058 crossref_primary_10_1136_ijgc_2021_002432 crossref_primary_10_1371_journal_pone_0270521 crossref_primary_10_1016_j_compbiomed_2024_108593 crossref_primary_10_3390_cancers13246351 crossref_primary_10_1055_a_1671_2158 crossref_primary_10_1109_ACCESS_2025_3538566 crossref_primary_10_7759_cureus_55930 crossref_primary_10_1002_cam4_4017 crossref_primary_10_3390_cells10092190 crossref_primary_10_3390_cells13110896 crossref_primary_10_1245_s10434_020_08329_5 crossref_primary_10_1007_s12672_024_00979_1 crossref_primary_10_1089_imr_2022_0067 crossref_primary_10_1093_jsxmed_qdaf083 crossref_primary_10_7554_eLife_97335_3 crossref_primary_10_1016_j_tim_2019_10_008 crossref_primary_10_3390_pharmaceutics13122057 crossref_primary_10_1016_j_gore_2024_101349 crossref_primary_10_1016_j_phrs_2023_106863 crossref_primary_10_1016_j_ygyno_2020_07_026 crossref_primary_10_1590_0034_7167_2021_0874pt crossref_primary_10_3389_fonc_2024_1400109 crossref_primary_10_1016_j_sajb_2023_10_067 crossref_primary_10_1016_j_arcmed_2020_05_025 crossref_primary_10_1016_j_tranon_2024_102001 crossref_primary_10_1186_s12885_020_6630_0 crossref_primary_10_3389_fphar_2022_1065793 crossref_primary_10_1002_btm2_10375 crossref_primary_10_1186_s12879_025_10840_7 crossref_primary_10_1016_S2214_109X_25_00279_7 crossref_primary_10_1080_15384101_2022_2039981 crossref_primary_10_1186_s12992_022_00890_w crossref_primary_10_3390_epigenomes7030016 crossref_primary_10_1088_1748_605X_ad3311 crossref_primary_10_1186_s41065_025_00365_z crossref_primary_10_1007_s11033_020_05685_z crossref_primary_10_1093_bjr_tqae084 crossref_primary_10_1186_s13014_021_01907_1 crossref_primary_10_1371_journal_ppat_1012815 crossref_primary_10_7759_cureus_64422 crossref_primary_10_1007_s12672_025_03287_4 crossref_primary_10_1016_j_cellsig_2024_111500 crossref_primary_10_1186_s13027_023_00488_w crossref_primary_10_2147_DDDT_S291865 crossref_primary_10_3389_fimmu_2023_1113369 crossref_primary_10_3390_cancers17183042 crossref_primary_10_1186_s12985_024_02405_y crossref_primary_10_1002_iub_2522 crossref_primary_10_1007_s43032_020_00149_y crossref_primary_10_1186_s12879_025_10522_4 crossref_primary_10_1111_jcmm_18081 crossref_primary_10_1002_JLB_5MA0322_746R crossref_primary_10_1016_j_canep_2023_102372 crossref_primary_10_1016_j_micpath_2024_106826 crossref_primary_10_1080_1040841X_2021_1905606 crossref_primary_10_1002_cyto_a_24684 crossref_primary_10_1016_j_compbiomed_2022_105994 crossref_primary_10_3389_fonc_2023_1143876 crossref_primary_10_3390_math9060679 crossref_primary_10_1186_s13027_025_00647_1 crossref_primary_10_1016_j_clnesp_2022_02_017 crossref_primary_10_1186_s12885_025_13974_8 crossref_primary_10_1186_s13287_023_03585_0 crossref_primary_10_1186_s12885_023_11372_6 crossref_primary_10_1002_cnr2_70306 crossref_primary_10_1080_14712598_2023_2182679 crossref_primary_10_2147_CMAR_S277064 crossref_primary_10_3389_fonc_2022_1011000 crossref_primary_10_1002_jcla_23793 crossref_primary_10_1007_s11033_024_09602_6 crossref_primary_10_2147_IJWH_S386689 crossref_primary_10_1002_kjm2_70076 crossref_primary_10_3390_healthcare11010144 crossref_primary_10_1002_sim_8681 crossref_primary_10_1136_ijgc_2020_001274 crossref_primary_10_1111_ecc_13550 crossref_primary_10_1186_s13046_020_01745_1 crossref_primary_10_1007_s00432_023_05563_8 crossref_primary_10_1111_jog_14139 crossref_primary_10_1016_j_csbj_2024_06_007 crossref_primary_10_1158_0008_5472_CAN_23_0067 crossref_primary_10_1080_21645515_2025_2483018 crossref_primary_10_1016_j_aca_2023_341651 crossref_primary_10_1016_j_ejso_2024_108438 crossref_primary_10_1111_cas_15723 crossref_primary_10_1016_j_vaccine_2021_07_094 crossref_primary_10_3389_fonc_2022_851367 crossref_primary_10_1007_s10943_020_01108_2 crossref_primary_10_1371_journal_pone_0282710 crossref_primary_10_3892_ol_2020_11754 crossref_primary_10_1017_S0950268822001066 crossref_primary_10_1186_s13014_022_02018_1 crossref_primary_10_1007_s12079_022_00696_w crossref_primary_10_1097_MD_0000000000039733 crossref_primary_10_1109_ACCESS_2024_3445371 crossref_primary_10_3390_medicina60101700 crossref_primary_10_1186_s12935_020_01299_4 crossref_primary_10_1016_j_jogoh_2021_102291 crossref_primary_10_1080_01443615_2021_1882974 crossref_primary_10_1111_cbdd_70059 crossref_primary_10_1111_aogs_14119 crossref_primary_10_1002_acm2_14479 crossref_primary_10_1007_s12672_023_00788_y crossref_primary_10_1186_s12985_025_02909_1 crossref_primary_10_1371_journal_pone_0267571 crossref_primary_10_1016_j_tipsro_2025_100315 crossref_primary_10_1007_s12672_023_00775_3 crossref_primary_10_3390_cancers14235764 crossref_primary_10_3389_fpubh_2025_1623627 crossref_primary_10_1038_s41467_024_45920_w crossref_primary_10_1093_aje_kwae044 crossref_primary_10_2147_IJGM_S411511 crossref_primary_10_1016_j_jep_2023_116969 crossref_primary_10_1038_s41746_023_00912_w crossref_primary_10_3389_fonc_2020_01444 crossref_primary_10_1007_s00404_021_06044_4 crossref_primary_10_3389_fonc_2025_1505512 crossref_primary_10_1016_j_jconrel_2025_113946 crossref_primary_10_1016_j_patcog_2024_111201 crossref_primary_10_1002_adfm_201904969 crossref_primary_10_1038_s41598_024_74871_x crossref_primary_10_1186_s13012_023_01322_y crossref_primary_10_1016_j_rechem_2025_102115 crossref_primary_10_2174_0118715206338559241112060553 crossref_primary_10_1002_smll_202301776 crossref_primary_10_3390_healthcare11030325 crossref_primary_10_1007_s00520_020_05554_2 crossref_primary_10_1155_2019_3257939 crossref_primary_10_3389_fonc_2024_1348288 crossref_primary_10_1007_s12094_024_03619_w crossref_primary_10_3389_fonc_2020_01433 crossref_primary_10_3389_fphar_2025_1538980 crossref_primary_10_1016_j_crad_2021_12_011 crossref_primary_10_3389_fonc_2022_887773 crossref_primary_10_1016_j_ijid_2025_108034 crossref_primary_10_1080_23311916_2022_2143040 crossref_primary_10_1002_jmv_29451 crossref_primary_10_1002_jvc2_589 crossref_primary_10_1186_s12943_024_02055_2 crossref_primary_10_3389_fcimb_2024_1280636 crossref_primary_10_1038_s41419_024_06522_y crossref_primary_10_1080_17458080_2021_2013470 crossref_primary_10_1038_s41419_021_04229_y crossref_primary_10_3389_fmed_2023_1225982 crossref_primary_10_1186_s12885_021_08580_3 crossref_primary_10_1080_21655979_2021_1880732 crossref_primary_10_1097_MD_0000000000023155 crossref_primary_10_3390_cancers14225500 crossref_primary_10_3389_fonc_2024_1526103 crossref_primary_10_1038_s41525_021_00244_2 crossref_primary_10_1136_bmjgh_2024_017622 crossref_primary_10_3892_ol_2019_10527 crossref_primary_10_1016_j_canlet_2020_10_034 crossref_primary_10_1177_1176934320920574 crossref_primary_10_1128_spectrum_03073_24 crossref_primary_10_1186_s13256_023_04171_x crossref_primary_10_3389_fimmu_2022_897366 crossref_primary_10_1097_MD_0000000000044069 crossref_primary_10_1007_s10495_019_01588_y crossref_primary_10_3389_fonc_2022_861392 crossref_primary_10_1038_s41420_022_01049_7 crossref_primary_10_1259_bjr_20201314 crossref_primary_10_1080_15384101_2021_2020962 crossref_primary_10_1007_s00432_023_04769_0 crossref_primary_10_3389_fnano_2025_1475969 crossref_primary_10_1055_s_0043_1775461 crossref_primary_10_1016_j_bmc_2020_115950 crossref_primary_10_1139_bcb_2022_0049 crossref_primary_10_3802_jgo_2026_37_e13 crossref_primary_10_1007_s00432_021_03884_0 crossref_primary_10_1016_j_intimp_2020_107091 crossref_primary_10_1007_s10791_025_09713_z crossref_primary_10_1111_jog_15421 crossref_primary_10_3390_toxins15010042 crossref_primary_10_3390_pharmaceutics16111420 crossref_primary_10_1186_s12913_024_11989_8 crossref_primary_10_3389_fonc_2021_784525 crossref_primary_10_1080_10408398_2024_2414828 crossref_primary_10_3389_fcimb_2024_1357090 crossref_primary_10_1080_21645515_2021_2007709 crossref_primary_10_1111_pin_13498 crossref_primary_10_1111_cas_14680 crossref_primary_10_3892_or_2022_8384 crossref_primary_10_1002_pro6_70019 crossref_primary_10_1016_j_chembiol_2025_02_002 crossref_primary_10_3390_diagnostics13061073 crossref_primary_10_1186_s40001_024_02230_7 crossref_primary_10_3389_fphar_2020_00271 crossref_primary_10_1177_11795549231180832 crossref_primary_10_1177_17588359231165974 crossref_primary_10_1016_j_jddst_2024_106379 crossref_primary_10_1002_agm2_12366 crossref_primary_10_2147_OTT_S282790 crossref_primary_10_3389_fonc_2022_1021453 crossref_primary_10_1177_2752535X251352995 crossref_primary_10_1136_bmjopen_2020_042364 crossref_primary_10_1016_j_modpat_2023_100316 crossref_primary_10_1016_j_prp_2025_156116 crossref_primary_10_1097_JCMA_0000000000001129 crossref_primary_10_1080_15384101_2021_1991106 crossref_primary_10_1111_apm_13159 crossref_primary_10_4103_GMIT_GMIT_121_20 crossref_primary_10_1016_j_bspc_2021_103373 crossref_primary_10_1186_s40360_020_00448_9 crossref_primary_10_1016_j_ijpharm_2025_125657 crossref_primary_10_1038_s41598_025_98359_4 crossref_primary_10_3389_fonc_2021_706862 crossref_primary_10_1111_jcmm_14593 crossref_primary_10_1080_21655979_2021_1947174 crossref_primary_10_1002_jmv_29244 crossref_primary_10_3390_app12157742 crossref_primary_10_1016_j_tice_2022_101845 crossref_primary_10_1038_s41698_024_00778_5 crossref_primary_10_3390_ijerph18010149 crossref_primary_10_1007_s11082_025_08369_9 crossref_primary_10_1097_COC_0000000000001092 crossref_primary_10_1016_j_annepidem_2023_04_013 crossref_primary_10_1007_s44196_025_00772_0 crossref_primary_10_1007_s12094_024_03604_3 crossref_primary_10_1007_s12672_024_00948_8 crossref_primary_10_1038_s41598_019_55786_4 crossref_primary_10_1080_02656736_2025_2450514 crossref_primary_10_1038_s41419_025_07768_w crossref_primary_10_1016_j_jcis_2023_03_178 crossref_primary_10_1016_j_radonc_2024_110328 crossref_primary_10_1186_s12885_021_08945_8 crossref_primary_10_1016_j_jiph_2023_07_013 crossref_primary_10_1038_s41598_024_64255_6 crossref_primary_10_1080_14737140_2021_1879646 crossref_primary_10_1186_s12967_021_02894_3 crossref_primary_10_3389_fmolb_2023_1247536 crossref_primary_10_1007_s00011_022_01560_8 crossref_primary_10_1007_s11356_021_17608_x crossref_primary_10_1016_j_ejmech_2024_116572 crossref_primary_10_1136_bmjopen_2021_052016 crossref_primary_10_1016_j_ijrobp_2022_11_011 crossref_primary_10_1089_cbr_2020_3865 crossref_primary_10_3390_electronics10161933 crossref_primary_10_5334_aogh_4576 crossref_primary_10_3892_etm_2019_8348 crossref_primary_10_3390_vaccines9101069 crossref_primary_10_3390_ma15010138 crossref_primary_10_1093_hmg_ddaf027 crossref_primary_10_1007_s12026_024_09493_6 crossref_primary_10_1136_bmjopen_2021_056848 crossref_primary_10_1016_j_ygyno_2023_12_014 crossref_primary_10_4102_ajlm_v13i1_2374 crossref_primary_10_1016_j_abb_2025_110389 crossref_primary_10_3889_oamjms_2023_11129 crossref_primary_10_1186_s12957_023_03051_4 crossref_primary_10_3389_fonc_2021_780387 crossref_primary_10_3389_fonc_2021_748681 crossref_primary_10_3390_diagnostics13243614 crossref_primary_10_1186_s12885_022_09531_2 crossref_primary_10_1111_ajco_14049 crossref_primary_10_3390_ijms241512494 crossref_primary_10_1016_j_apsb_2023_03_025 crossref_primary_10_1016_j_canlet_2023_216408 crossref_primary_10_2217_fvl_2024_0020 crossref_primary_10_3892_mmr_2021_12457 crossref_primary_10_1097_01_JAA_0000769656_60157_95 crossref_primary_10_3389_fcell_2021_756458 crossref_primary_10_1002_jmv_28857 crossref_primary_10_3389_fonc_2024_1488730 crossref_primary_10_1149_1945_7111_addb80 crossref_primary_10_1007_s00018_022_04598_3 crossref_primary_10_1186_s12905_022_01668_3 crossref_primary_10_1371_journal_pone_0325805 crossref_primary_10_1155_2022_9675466 crossref_primary_10_1016_j_acra_2023_09_031 crossref_primary_10_1097_LGT_0000000000000759 crossref_primary_10_2217_epi_2024_0002 crossref_primary_10_1186_s13046_020_01793_7 crossref_primary_10_3390_vaccines12020206 crossref_primary_10_1016_j_yexmp_2021_104734 crossref_primary_10_3389_fonc_2021_700710 crossref_primary_10_3390_diagnostics12081906 crossref_primary_10_1177_17455057251326008 crossref_primary_10_1007_s43032_022_00855_9 crossref_primary_10_1007_s00432_023_05267_z crossref_primary_10_1016_j_jmig_2023_11_019 crossref_primary_10_1097_MD_0000000000027690 crossref_primary_10_1186_s12885_022_09506_3 crossref_primary_10_3390_computation11120252 crossref_primary_10_1186_s12935_020_01430_5 crossref_primary_10_1039_D2QM00217E crossref_primary_10_3390_cancers17091558 crossref_primary_10_1007_s40615_024_02148_0 crossref_primary_10_1002_2211_5463_13298 crossref_primary_10_1038_s41598_024_73601_7 crossref_primary_10_1186_s12935_019_1048_y crossref_primary_10_3389_fmolb_2020_00107 crossref_primary_10_3389_fonc_2021_755668 crossref_primary_10_1016_j_sjbs_2021_05_004 crossref_primary_10_1002_cnr2_70294 crossref_primary_10_1016_j_pdpdt_2025_104697 crossref_primary_10_1016_j_mri_2022_05_019 crossref_primary_10_3389_fonc_2022_910486 crossref_primary_10_1016_j_jsbmb_2021_105990 crossref_primary_10_1002_nau_24587 crossref_primary_10_1186_s13048_020_00730_8 crossref_primary_10_1186_s12885_025_13901_x crossref_primary_10_3389_fmed_2021_725298 crossref_primary_10_1038_s41598_022_17733_8 crossref_primary_10_1155_2022_8550817 crossref_primary_10_3389_fmed_2025_1562818 crossref_primary_10_1002_acm2_14097 crossref_primary_10_1186_s12885_022_10331_x crossref_primary_10_1080_01635581_2020_1801777 crossref_primary_10_1038_s41598_020_75512_9 crossref_primary_10_1177_03008916251341993 crossref_primary_10_1016_j_pdpdt_2021_102394 crossref_primary_10_2147_CMAR_S327056 crossref_primary_10_1016_j_jddst_2023_104810 crossref_primary_10_3389_fimmu_2023_1259723 crossref_primary_10_4103_jehp_jehp_1842_22 crossref_primary_10_1016_j_ygyno_2022_07_009 crossref_primary_10_1177_15330338231164191 crossref_primary_10_1186_s12885_025_14637_4 crossref_primary_10_3389_fmicb_2024_1352778 crossref_primary_10_1016_j_gore_2022_101131 crossref_primary_10_1186_s12905_023_02451_8 crossref_primary_10_1002_jmv_28410 crossref_primary_10_1016_j_tjog_2021_07_030 crossref_primary_10_1186_s12864_024_10411_1 crossref_primary_10_1097_CM9_0000000000003795 crossref_primary_10_1007_s00216_020_02843_x crossref_primary_10_1007_s13402_020_00582_w crossref_primary_10_1097_MD_0000000000038116 crossref_primary_10_1007_s00432_024_05710_9 crossref_primary_10_1038_s41598_025_07201_4 crossref_primary_10_1002_agt2_70008 crossref_primary_10_1007_s00261_025_05146_w crossref_primary_10_1017_S0950268821001904 crossref_primary_10_3389_fnut_2023_1094081 crossref_primary_10_3892_ol_2024_14689 crossref_primary_10_31083_j_ceog5009179 crossref_primary_10_1016_j_brachy_2023_06_004 crossref_primary_10_3389_fonc_2021_684477 crossref_primary_10_1177_03936155231163599 crossref_primary_10_1007_s12668_024_01728_y crossref_primary_10_1186_s12859_022_04949_8 crossref_primary_10_1186_s12935_020_01594_0 crossref_primary_10_3389_fonc_2022_786266 crossref_primary_10_1002_cbdv_202402398 crossref_primary_10_3892_mco_2021_2370 crossref_primary_10_1002_cam4_71194 crossref_primary_10_1007_s42114_025_01242_z crossref_primary_10_1080_01443615_2023_2213328 crossref_primary_10_1136_ijgc_2020_001740 crossref_primary_10_1016_j_mtbio_2025_101551 crossref_primary_10_1080_17425247_2020_1747429 crossref_primary_10_2147_JIR_S528121 crossref_primary_10_3389_fcell_2021_677867 crossref_primary_10_1007_s10876_020_01766_y crossref_primary_10_1080_14656566_2024_2395379 crossref_primary_10_1136_ijgc_2020_001504 crossref_primary_10_1007_s12672_025_02532_0 crossref_primary_10_1371_journal_pone_0273375 crossref_primary_10_3390_biom12091296 crossref_primary_10_1177_11795972251351815 crossref_primary_10_1371_journal_pone_0247905 crossref_primary_10_2147_IJGM_S353576 crossref_primary_10_3390_ijerph19116858 crossref_primary_10_3390_medicina59040777 crossref_primary_10_1038_s41420_024_02259_x crossref_primary_10_1016_j_jcis_2024_11_221 crossref_primary_10_1200_EDBK_25_481126 crossref_primary_10_1371_journal_pone_0323680 crossref_primary_10_1007_s12672_024_01213_8 crossref_primary_10_1016_j_yexcr_2023_113458 crossref_primary_10_1016_j_adcanc_2023_100097 crossref_primary_10_1186_s12986_021_00615_7 crossref_primary_10_1002_cbf_70065 crossref_primary_10_3389_fimmu_2020_598877 crossref_primary_10_7759_cureus_77389 crossref_primary_10_1002_jbt_23462 crossref_primary_10_1016_j_ctro_2021_10_005 crossref_primary_10_1007_s10103_025_04537_1 crossref_primary_10_1007_s12013_024_01251_7 crossref_primary_10_1016_j_meegid_2022_105365 crossref_primary_10_1016_j_compbiomed_2023_107656 crossref_primary_10_1016_j_biosx_2025_100658 crossref_primary_10_1016_j_neucom_2024_128630 crossref_primary_10_62347_GGVE9638 crossref_primary_10_3389_fsurg_2021_759026 crossref_primary_10_3389_fonc_2022_994726 crossref_primary_10_1007_s10528_023_10534_2 crossref_primary_10_1089_heq_2020_0133 crossref_primary_10_3389_fgene_2024_1391842 crossref_primary_10_1021_acs_jproteome_5c00304 crossref_primary_10_1111_jog_16126 crossref_primary_10_5798_dicletip_579312 crossref_primary_10_1111_bph_16308 crossref_primary_10_1111_imm_13682 crossref_primary_10_1097_MD_0000000000040408 crossref_primary_10_1007_s10904_024_03347_2 crossref_primary_10_1111_1471_0528_17098 crossref_primary_10_3390_diagnostics15080985 crossref_primary_10_17749_2313_7347_ob_gyn_rep_2025_617 crossref_primary_10_1007_s41664_024_00328_9 crossref_primary_10_1038_s41416_020_0831_9 crossref_primary_10_3802_jgo_2025_36_e113 crossref_primary_10_1007_s12013_024_01405_7 crossref_primary_10_3389_fphar_2023_1156629 crossref_primary_10_3892_ol_2022_13349 crossref_primary_10_1007_s12032_024_02410_9 crossref_primary_10_1038_s41416_020_01123_w crossref_primary_10_3389_fgene_2021_663617 crossref_primary_10_3389_fonc_2021_761901 crossref_primary_10_3389_fgene_2022_933798 crossref_primary_10_3390_stats5020021 crossref_primary_10_1016_j_compbiomed_2023_106574 crossref_primary_10_2147_IJN_S493074 crossref_primary_10_1007_s10552_022_01638_y crossref_primary_10_1016_j_vaccine_2021_06_074 crossref_primary_10_1016_j_jff_2022_105267 crossref_primary_10_1177_1533033821989711 crossref_primary_10_1111_hex_14038 crossref_primary_10_1002_cac2_12451 crossref_primary_10_1002_cbdv_201900366 crossref_primary_10_3390_cancers12071803 crossref_primary_10_1080_03630242_2023_2223670 crossref_primary_10_1186_s12905_023_02264_9 crossref_primary_10_1007_s00261_024_04339_z crossref_primary_10_1111_jcmm_17204 crossref_primary_10_1186_s12885_025_13509_1 crossref_primary_10_1515_med_2021_0218 crossref_primary_10_1155_2021_1544784 crossref_primary_10_3390_ma14133622 crossref_primary_10_3892_ol_2020_11622 crossref_primary_10_1016_j_cca_2024_120103 crossref_primary_10_3390_ijms252312991 crossref_primary_10_3390_vaccines10122113 crossref_primary_10_1016_j_jogc_2025_103052 crossref_primary_10_3389_fonc_2024_1436095 crossref_primary_10_1016_j_csbj_2025_08_007 crossref_primary_10_1177_20503121241252265 crossref_primary_10_3389_fmed_2024_1294230 crossref_primary_10_1186_s13046_023_02839_2 crossref_primary_10_1097_CJI_0000000000000545 crossref_primary_10_1016_j_tranon_2021_101058 crossref_primary_10_1038_s41392_021_00507_5 crossref_primary_10_1038_s41598_021_04618_5 crossref_primary_10_31083_j_ceog4912273 crossref_primary_10_1007_s43450_022_00290_6 crossref_primary_10_1038_s41417_021_00355_z crossref_primary_10_1007_s12668_024_01496_9 crossref_primary_10_3389_fcell_2020_603516 crossref_primary_10_1186_s12935_021_01910_2 crossref_primary_10_1001_jamanetworkopen_2022_54075 crossref_primary_10_1186_s13027_024_00573_8 crossref_primary_10_1088_1757_899X_917_1_012068 crossref_primary_10_1080_14796694_2025_2461444 crossref_primary_10_1186_s12935_021_01749_7 crossref_primary_10_3389_fonc_2024_1380448 crossref_primary_10_1186_s12935_021_02319_7 crossref_primary_10_1002_cncr_33628 crossref_primary_10_1016_j_hoc_2019_08_018 crossref_primary_10_3390_biom11010037 crossref_primary_10_3389_fonc_2022_1002040 crossref_primary_10_1016_j_etap_2020_103514 crossref_primary_10_3389_fgene_2022_957744 crossref_primary_10_1186_s40644_024_00747_y crossref_primary_10_1038_s41420_024_02279_7 crossref_primary_10_3390_cancers16030476 crossref_primary_10_1097_MD_0000000000027056 crossref_primary_10_1016_j_bbrc_2025_152084 crossref_primary_10_1016_j_genrep_2021_101397 crossref_primary_10_3389_fonc_2023_1160626 crossref_primary_10_3390_cancers16162804 crossref_primary_10_1038_s41598_025_09168_8 crossref_primary_10_1016_j_biopha_2019_109444 crossref_primary_10_1038_s41419_023_06033_2 crossref_primary_10_1016_j_ejon_2023_102320 crossref_primary_10_3802_jgo_2025_36_e121 crossref_primary_10_3892_ol_2021_13126 crossref_primary_10_1186_s12905_024_02884_9 crossref_primary_10_1016_j_biopha_2023_115982 crossref_primary_10_1016_j_humgen_2022_201131 crossref_primary_10_1016_j_saa_2024_125353 crossref_primary_10_1007_s12032_022_01646_7 crossref_primary_10_1007_s12094_024_03743_7 crossref_primary_10_1016_j_semcancer_2023_09_005 crossref_primary_10_3233_XST_230212 crossref_primary_10_1007_s00404_021_05968_1 crossref_primary_10_1016_j_ygyno_2021_12_002 crossref_primary_10_1155_2022_5936773 crossref_primary_10_1016_j_bbrc_2021_03_020 crossref_primary_10_1038_s41417_020_00238_9 crossref_primary_10_3389_fonc_2025_1519103 crossref_primary_10_1016_j_bjp_2019_06_004 crossref_primary_10_1007_s11356_022_20597_0 crossref_primary_10_1007_s00129_022_04993_8 crossref_primary_10_1016_j_tranon_2025_102487 crossref_primary_10_1007_s11912_022_01317_w crossref_primary_10_1007_s41939_025_00834_y crossref_primary_10_1007_s00216_022_04296_w crossref_primary_10_1016_j_biopha_2023_114882 crossref_primary_10_1210_clinem_dgac545 crossref_primary_10_1016_j_clon_2024_103702 crossref_primary_10_1080_13543784_2023_2179483 crossref_primary_10_3389_fonc_2019_01106 crossref_primary_10_1002_wnan_1718 crossref_primary_10_3389_fonc_2024_1460543 crossref_primary_10_5858_arpa_2023_0255_OA crossref_primary_10_1002_jcla_23340 crossref_primary_10_1002_jso_27633 crossref_primary_10_1155_2021_6699131 crossref_primary_10_1007_s00404_020_05916_5 crossref_primary_10_1038_s41392_024_01828_x crossref_primary_10_1007_s10462_023_10588_z crossref_primary_10_3390_diagnostics15131579 crossref_primary_10_1111_1471_0528_17285 crossref_primary_10_1097_CJI_0000000000000574 crossref_primary_10_1016_j_jcvp_2024_100182 crossref_primary_10_1016_j_saa_2025_126725 crossref_primary_10_1016_j_biopha_2020_110209 crossref_primary_10_1038_s41417_020_0164_0 crossref_primary_10_1155_2022_3921095 crossref_primary_10_1097_JCMA_0000000000000613 crossref_primary_10_4103_mjdrdypu_mjdrdypu_149_24 crossref_primary_10_1093_carcin_bgac073 crossref_primary_10_1016_j_abb_2024_109980 crossref_primary_10_1080_01443615_2022_2037124 crossref_primary_10_1016_j_radphyschem_2024_112407 crossref_primary_10_1080_01635581_2021_1936082 crossref_primary_10_3389_fonc_2022_946029 crossref_primary_10_3389_fonc_2024_1483882 crossref_primary_10_1038_s41420_022_01120_3 crossref_primary_10_1080_13697137_2024_2418503 crossref_primary_10_1177_03008916211014274 crossref_primary_10_3390_jcm14113784 crossref_primary_10_3389_fimmu_2024_1461894 crossref_primary_10_3389_fcell_2021_646981 crossref_primary_10_3390_cancers16101842 crossref_primary_10_1186_s12894_023_01239_0 crossref_primary_10_1186_s40364_024_00655_0 crossref_primary_10_1016_j_vaccine_2021_02_040 crossref_primary_10_1136_ijgc_2020_001351 crossref_primary_10_1016_j_prp_2024_155315 crossref_primary_10_1016_j_mri_2022_07_005 crossref_primary_10_1177_20552076231203802 crossref_primary_10_1186_s41065_025_00478_5 crossref_primary_10_2147_OTT_S291812 crossref_primary_10_1016_j_phymed_2024_155858 crossref_primary_10_1016_j_ygyno_2020_05_004 crossref_primary_10_1097_MD_0000000000032855 crossref_primary_10_1007_s12094_019_02271_z crossref_primary_10_1097_CEJ_0000000000000978 crossref_primary_10_1186_s12575_021_00154_8 crossref_primary_10_3389_fphar_2022_955482 crossref_primary_10_1080_17520363_2025_2483495 crossref_primary_10_1208_s12249_024_02813_x crossref_primary_10_2174_0115733947308352240729162826 crossref_primary_10_3390_healthcare11162273 crossref_primary_10_1016_j_tranon_2022_101539 crossref_primary_10_1007_s13258_023_01461_y crossref_primary_10_1007_s00330_021_07735_x crossref_primary_10_1080_13561820_2024_2327621 crossref_primary_10_1093_lifemeta_loae017 crossref_primary_10_1136_ijgc_2020_001587 crossref_primary_10_1016_j_arabjc_2022_103781 crossref_primary_10_1186_s12885_024_12435_y crossref_primary_10_1002_cac2_12629 crossref_primary_10_1080_00051144_2023_2196114 crossref_primary_10_1089_jpm_2021_0006 crossref_primary_10_1186_s13027_021_00395_y crossref_primary_10_1016_j_cca_2019_09_024 crossref_primary_10_3390_ijms25042237 crossref_primary_10_1128_spectrum_03896_22 crossref_primary_10_1186_s13027_021_00371_6 crossref_primary_10_4081_ejh_2025_4238 crossref_primary_10_3389_fimmu_2024_1351908 crossref_primary_10_1016_j_micpath_2024_106764 crossref_primary_10_1371_journal_pone_0280052 crossref_primary_10_3390_vaccines10020228 crossref_primary_10_1016_j_ijbiomac_2024_131862 crossref_primary_10_3389_fonc_2024_1392639 crossref_primary_10_4252_wjsc_v17_i3_99472 crossref_primary_10_1186_s12885_022_09737_4 crossref_primary_10_12998_wjcc_v12_i8_1510 crossref_primary_10_3389_fphar_2022_967633 crossref_primary_10_3389_fphar_2024_1351363 crossref_primary_10_3390_cancers13092092 crossref_primary_10_3390_cells11193074 crossref_primary_10_1016_j_microc_2025_113447 crossref_primary_10_1186_s13244_022_01269_6 crossref_primary_10_1136_ijgc_2024_005418 crossref_primary_10_3892_ol_2024_14461 crossref_primary_10_1111_febs_16681 crossref_primary_10_1128_spectrum_05117_22 crossref_primary_10_2217_fon_2020_0389 crossref_primary_10_1016_j_heliyon_2024_e40860 crossref_primary_10_1089_cbr_2019_3392 crossref_primary_10_3389_fonc_2021_615439 crossref_primary_10_3390_antiox13050617 crossref_primary_10_1016_j_jinorgbio_2022_111946 crossref_primary_10_1016_j_xagr_2025_100526 crossref_primary_10_1007_s10552_025_02023_1 crossref_primary_10_1016_j_bios_2023_115059 crossref_primary_10_1007_s11547_023_01705_7 crossref_primary_10_1158_0008_5472_CAN_19_0116 crossref_primary_10_1002_jmv_28834 crossref_primary_10_31083_j_fbl2708238 crossref_primary_10_1007_s00129_021_04861_x crossref_primary_10_1016_j_heliyon_2024_e26116 crossref_primary_10_1016_j_cegh_2025_102002 crossref_primary_10_1016_j_mri_2021_12_008 crossref_primary_10_1002_2211_5463_13228 crossref_primary_10_1016_j_optlaseng_2024_108426 crossref_primary_10_1038_s41401_021_00616_5 crossref_primary_10_1097_MD_0000000000031990 crossref_primary_10_1007_s40258_020_00576_7 crossref_primary_10_1371_journal_pone_0298815 crossref_primary_10_2196_40657 crossref_primary_10_1080_09553002_2024_2374903 crossref_primary_10_2147_CMAR_S293268 crossref_primary_10_1016_j_heliyon_2023_e20747 crossref_primary_10_1038_s41598_024_81726_y crossref_primary_10_1016_j_semcancer_2020_12_021 crossref_primary_10_1371_journal_pone_0284673 crossref_primary_10_2147_OTT_S272292 crossref_primary_10_3389_fonc_2021_706043 crossref_primary_10_1002_ima_22666 crossref_primary_10_2147_RMHP_S278809 crossref_primary_10_1002_cam4_7389 crossref_primary_10_1016_j_medj_2024_100573 crossref_primary_10_1155_2022_2606928 crossref_primary_10_1016_j_respe_2022_05_008 crossref_primary_10_3390_healthcare11202798 crossref_primary_10_3389_fimmu_2024_1522655 crossref_primary_10_3892_ol_2019_11098 crossref_primary_10_3390_antiox12101806 crossref_primary_10_1007_s10943_025_02435_y crossref_primary_10_1186_s12935_021_02123_3 crossref_primary_10_1186_s13046_020_01659_y crossref_primary_10_3389_fonc_2022_1049773 crossref_primary_10_1080_15376516_2023_2207644 crossref_primary_10_1097_MD_0000000000034313 crossref_primary_10_1016_j_ygyno_2024_08_021 crossref_primary_10_1016_j_bspc_2023_105887 crossref_primary_10_1016_j_micpath_2020_104438 crossref_primary_10_3389_fonc_2024_1466264 crossref_primary_10_1016_j_prp_2019_152621 crossref_primary_10_1016_j_critrevonc_2021_103343 crossref_primary_10_1111_cas_14119 crossref_primary_10_3390_vaccines9040329 crossref_primary_10_1002_advs_202302340 crossref_primary_10_1016_j_ymeth_2022_05_004 crossref_primary_10_1016_j_trac_2022_116686 crossref_primary_10_1371_journal_pone_0319812 crossref_primary_10_3889_oamjms_2023_8200 crossref_primary_10_3389_fmicb_2025_1615944 crossref_primary_10_1016_j_ejogrb_2022_12_005 crossref_primary_10_1016_j_brachy_2024_05_004 crossref_primary_10_3390_ijerph191811641 crossref_primary_10_1016_j_prp_2024_155488 crossref_primary_10_1186_s12879_021_06380_5 crossref_primary_10_1016_j_micpath_2023_106465 crossref_primary_10_1002_jcp_30134 crossref_primary_10_1016_j_radonc_2023_109524 crossref_primary_10_3390_ijms26031097 crossref_primary_10_1371_journal_pone_0300180 crossref_primary_10_1080_01443615_2024_2361858 crossref_primary_10_1111_iji_12626 crossref_primary_10_3390_cancers14184352 crossref_primary_10_1136_jitc_2021_003887 crossref_primary_10_3389_fimmu_2022_851622 crossref_primary_10_3390_cancers16203495 crossref_primary_10_4103_ijmr_IJMR_198_20 crossref_primary_10_2147_CMAR_S282989 crossref_primary_10_2147_IJN_S524518 crossref_primary_10_3389_fcimb_2024_1443868 crossref_primary_10_1159_000526700 crossref_primary_10_1016_j_cancergen_2025_08_001 crossref_primary_10_1016_j_ebiom_2020_103017 crossref_primary_10_1016_j_micpath_2024_106960 crossref_primary_10_1017_erm_2024_30 crossref_primary_10_1111_jog_15994 crossref_primary_10_2174_1574893618666230428095114 crossref_primary_10_1002_1878_0261_13538 crossref_primary_10_1111_jog_15998 crossref_primary_10_1371_journal_pone_0261503 crossref_primary_10_1155_2020_4947381 crossref_primary_10_3390_biom12070924 crossref_primary_10_1097_MD_0000000000033201 crossref_primary_10_3390_cancers14184382 crossref_primary_10_1007_s10616_025_00735_5 crossref_primary_10_7554_eLife_97335 crossref_primary_10_12677_WJCR_2024_141009 crossref_primary_10_1007_s00761_020_00758_x crossref_primary_10_1016_j_intimp_2023_111296 crossref_primary_10_1016_j_yexcr_2021_112649 crossref_primary_10_1038_s41598_022_08445_0 crossref_primary_10_12968_hmed_2024_0156 crossref_primary_10_1080_07391102_2023_2248260 crossref_primary_10_1038_s41417_020_00283_4 crossref_primary_10_61186_rbmb_12_1_120 crossref_primary_10_1186_s12905_025_03765_5 crossref_primary_10_1007_s11760_025_04098_4 crossref_primary_10_1371_journal_pone_0316323 crossref_primary_10_1016_j_talanta_2024_126839 crossref_primary_10_1186_s12920_020_00800_2 crossref_primary_10_7759_cureus_55871 crossref_primary_10_1016_j_radonc_2023_109748 crossref_primary_10_3389_fphar_2021_671138 crossref_primary_10_1515_fzm_2024_0012 crossref_primary_10_1016_j_mucimm_2024_03_007 crossref_primary_10_1016_j_ygyno_2023_06_581 crossref_primary_10_1002_adfm_202309984 crossref_primary_10_4103_jmp_jmp_65_25 crossref_primary_10_1097_MD_0000000000043015 crossref_primary_10_1177_10732748231195681 crossref_primary_10_1186_s12967_023_04623_4 crossref_primary_10_1186_s12885_022_10118_0 crossref_primary_10_31083_j_ceog5104081 crossref_primary_10_1186_s40364_023_00484_7 crossref_primary_10_1016_j_ijid_2021_07_011 crossref_primary_10_3389_fonc_2024_1412660 crossref_primary_10_1016_j_vaccine_2023_04_072 crossref_primary_10_3390_cancers17071188 crossref_primary_10_1016_j_jddst_2020_102127 crossref_primary_10_1136_ijgc_2022_003971 crossref_primary_10_1007_s11596_024_2898_7 crossref_primary_10_3390_molecules30132708 crossref_primary_10_3389_fonc_2025_1598883 crossref_primary_10_1016_j_ygyno_2022_05_006 crossref_primary_10_1016_j_canlet_2022_215917 crossref_primary_10_1080_10255842_2025_2475483 crossref_primary_10_1002_cam4_4369 crossref_primary_10_1016_j_bspc_2022_104235 crossref_primary_10_1097_MD_0000000000029163 crossref_primary_10_1016_j_prp_2024_155275 crossref_primary_10_1177_11769351221148588 crossref_primary_10_1128_spectrum_01843_24 crossref_primary_10_18203_2320_1770_ijrcog20251560 crossref_primary_10_3389_fcell_2024_1465729 crossref_primary_10_1007_s40268_022_00399_y crossref_primary_10_1371_journal_pgph_0003918 crossref_primary_10_1007_s11845_023_03501_8 crossref_primary_10_1177_20503121231180413 crossref_primary_10_1016_j_tranon_2025_102473 crossref_primary_10_3389_fgene_2022_988207 crossref_primary_10_1016_j_tranon_2025_102470 crossref_primary_10_1038_s41392_024_01980_4 crossref_primary_10_2147_CMAR_S312469 crossref_primary_10_2174_0929867330666230214101837 crossref_primary_10_2217_nnm_2023_0144 crossref_primary_10_1007_s00292_021_01051_3 crossref_primary_10_1038_s41416_022_01954_9 crossref_primary_10_1111_jog_15715 crossref_primary_10_1016_j_jep_2022_115820 crossref_primary_10_1007_s13402_020_00555_z crossref_primary_10_3390_cells10030668 crossref_primary_10_1002_ijgo_15600 crossref_primary_10_18016_ksutarimdoga_vi_707661 crossref_primary_10_1007_s00044_020_02622_4 crossref_primary_10_3390_molecules26102858 crossref_primary_10_3390_ijms25168775 crossref_primary_10_1007_s00292_019_00675_w crossref_primary_10_1007_s00404_024_07746_1 crossref_primary_10_3389_fpubh_2025_1633975 crossref_primary_10_1097_PAI_0000000000001226 crossref_primary_10_1186_s12985_024_02502_y crossref_primary_10_1002_cyto_a_24349 crossref_primary_10_1111_cas_15246 crossref_primary_10_1002_jcla_23893 crossref_primary_10_1097_CAD_0000000000000899 crossref_primary_10_3390_pathogens14030293 crossref_primary_10_1016_j_ultrasmedbio_2024_07_013 crossref_primary_10_3389_fonc_2025_1457253 crossref_primary_10_1186_s13048_021_00789_x crossref_primary_10_1002_tox_24270 crossref_primary_10_1097_MD_0000000000034977 crossref_primary_10_3389_fphar_2021_808144 crossref_primary_10_1080_01443615_2024_2361847 crossref_primary_10_1096_fj_202201189RR crossref_primary_10_1016_j_phro_2025_100793 crossref_primary_10_1097_MD_0000000000042120 crossref_primary_10_1002_cam4_5477 crossref_primary_10_1007_s40944_022_00702_4 crossref_primary_10_1016_j_gore_2025_101792 crossref_primary_10_1371_journal_pone_0255289 crossref_primary_10_1038_s41598_024_65957_7 crossref_primary_10_3389_fonc_2022_857375 crossref_primary_10_1097_PGP_0000000000001007 crossref_primary_10_3389_fonc_2022_999643 crossref_primary_10_1002_kjm2_12432 crossref_primary_10_1016_j_ejmech_2024_116850 crossref_primary_10_3390_molecules26144214 crossref_primary_10_1097_DAD_0000000000002846 crossref_primary_10_31744_einstein_journal_2025AO1154 crossref_primary_10_3389_fmolb_2022_872932 crossref_primary_10_2147_PGPM_S422083 crossref_primary_10_1002_tox_24283 crossref_primary_10_1007_s40944_022_00639_8 crossref_primary_10_1016_j_ctro_2024_100793 crossref_primary_10_1159_000511477 crossref_primary_10_1186_s13148_023_01537_2 crossref_primary_10_1007_s11010_021_04249_4 crossref_primary_10_1016_j_lfs_2019_06_016 crossref_primary_10_1186_s12985_022_01776_4 crossref_primary_10_3390_diagnostics11122354 crossref_primary_10_1016_j_ijid_2021_06_024 crossref_primary_10_1016_S1470_2045_19_30389_4 crossref_primary_10_1089_gtmb_2020_0313 crossref_primary_10_3389_fonc_2022_857138 crossref_primary_10_1007_s00330_021_08279_w crossref_primary_10_1007_s12672_025_03460_9 crossref_primary_10_3389_fphar_2020_00544 crossref_primary_10_1007_s11864_023_01128_6 crossref_primary_10_1111_febs_16384 crossref_primary_10_3390_ijms232012554 crossref_primary_10_1016_j_heliyon_2024_e38951 crossref_primary_10_3892_or_2022_8414 crossref_primary_10_1080_14796694_2024_2342241 crossref_primary_10_1136_bmjopen_2021_055470 crossref_primary_10_1097_MD_0000000000019372 crossref_primary_10_1111_jog_14404 crossref_primary_10_1088_1361_6528_ad5297 crossref_primary_10_1186_s12985_025_02830_7 crossref_primary_10_1016_j_ajpath_2024_01_016 crossref_primary_10_1038_s41388_021_02002_1 crossref_primary_10_1186_s13027_022_00466_8 crossref_primary_10_3389_fonc_2022_942380 crossref_primary_10_1016_j_urology_2024_09_029 crossref_primary_10_1016_j_arabjc_2023_105011 crossref_primary_10_3390_medicina58020190 crossref_primary_10_1371_journal_pone_0304396 crossref_primary_10_1186_s12880_024_01191_x crossref_primary_10_1186_s13000_021_01182_4 crossref_primary_10_3389_fcell_2021_605301 crossref_primary_10_1088_1758_5090_adae38 crossref_primary_10_1136_ijgc_2023_004935 crossref_primary_10_3390_cancers13225737 crossref_primary_10_1007_s11302_020_09693_3 crossref_primary_10_1016_j_yexcr_2024_114060 crossref_primary_10_1080_08941939_2021_2013578 crossref_primary_10_1002_iub_2450 crossref_primary_10_3390_ma17051050 crossref_primary_10_3389_fonc_2022_1003930 crossref_primary_10_3390_cancers14010212 crossref_primary_10_3390_cancers16183169 crossref_primary_10_1111_jog_15359 crossref_primary_10_3390_cancers14010211 crossref_primary_10_3390_molecules27144523 crossref_primary_10_3390_cancers14081872 crossref_primary_10_1007_s12291_023_01137_0 crossref_primary_10_18502_jett_v13i2_18798 crossref_primary_10_1111_jog_15110 crossref_primary_10_3390_cancers15010087 crossref_primary_10_3389_fonc_2022_856944 crossref_primary_10_1080_14635240_2023_2201273 crossref_primary_10_1177_09691413211039254 crossref_primary_10_1002_pro6_1202 crossref_primary_10_1111_cge_13717 crossref_primary_10_3390_jcm10030437 crossref_primary_10_3389_fmolb_2021_583028 crossref_primary_10_7554_eLife_86266 crossref_primary_10_1016_j_arabjc_2024_105992 crossref_primary_10_1136_ijgc_2023_004703 crossref_primary_10_1016_j_colsurfb_2019_110762 crossref_primary_10_1136_bmjopen_2022_062678 crossref_primary_10_1080_01443615_2023_2194991 crossref_primary_10_3390_cancers13225748 crossref_primary_10_1007_s13577_021_00644_7 crossref_primary_10_1016_j_mtcomm_2024_109432 crossref_primary_10_1109_ACCESS_2024_3519806 crossref_primary_10_3390_cancers14122969 crossref_primary_10_1038_s41598_024_64574_8 crossref_primary_10_1007_s15004_021_8701_z crossref_primary_10_1016_j_radonc_2021_10_015 crossref_primary_10_1371_journal_pone_0270874 crossref_primary_10_3390_cancers17152421 crossref_primary_10_1002_cam4_6526 crossref_primary_10_1177_1533033821997825 crossref_primary_10_3889_oamjms_2023_11688 crossref_primary_10_1007_s10552_022_01642_2 crossref_primary_10_1038_s41571_024_00904_z crossref_primary_10_3389_fonc_2023_1105482 crossref_primary_10_1007_s10528_024_10865_8 crossref_primary_10_1097_CM9_0000000000001665 crossref_primary_10_1186_s12889_025_22319_w crossref_primary_10_1038_s41467_024_51633_x crossref_primary_10_2147_IJGM_S372154 crossref_primary_10_1186_s12889_025_21884_4 crossref_primary_10_1038_s41598_024_84422_z crossref_primary_10_1080_07853890_2024_2404548 crossref_primary_10_1093_jmcb_mjae046 crossref_primary_10_1097_CIN_0000000000001314 crossref_primary_10_1002_jmv_29571 crossref_primary_10_1016_j_microc_2022_107818 crossref_primary_10_1097_MD_0000000000029818 crossref_primary_10_1186_s12879_022_07893_3 crossref_primary_10_3389_fonc_2022_1003951 crossref_primary_10_1371_journal_pone_0269655 crossref_primary_10_1016_j_molstruc_2021_132186 crossref_primary_10_1016_j_ejso_2024_108583 crossref_primary_10_1002_iub_2686 crossref_primary_10_1007_s10552_023_01799_4 crossref_primary_10_5498_wjp_v15_i4_103510 crossref_primary_10_1186_s12905_023_02829_8 crossref_primary_10_1080_01443615_2020_1737662 crossref_primary_10_1016_j_genrep_2025_102272 crossref_primary_10_2147_CMAR_S265336 crossref_primary_10_1016_j_ijbiomac_2022_03_103 crossref_primary_10_1590_0102_311x00002220 crossref_primary_10_1038_s41419_023_05583_9 crossref_primary_10_1007_s13258_020_00938_4 crossref_primary_10_1093_jjco_hyaa251 crossref_primary_10_1002_slct_202200655 crossref_primary_10_1016_j_pdpdt_2024_104022 crossref_primary_10_3390_cancers14122913 crossref_primary_10_1080_15384101_2022_2109362 crossref_primary_10_4103_jehp_jehp_318_23 crossref_primary_10_1016_j_puhip_2023_100417 crossref_primary_10_1016_j_vaccine_2022_08_020 crossref_primary_10_3390_jnt1010003 crossref_primary_10_1158_1940_6207_CAPR_25_0029 crossref_primary_10_1155_2023_4164232 crossref_primary_10_1159_000530347 crossref_primary_10_3389_fonc_2023_1287121 crossref_primary_10_1136_ijgc_2021_003004 crossref_primary_10_1186_s13014_024_02432_7 crossref_primary_10_1055_s_0043_1772483 crossref_primary_10_3892_mmr_2021_12526 crossref_primary_10_1016_j_lfs_2020_118190 crossref_primary_10_1002_jcp_31267 crossref_primary_10_3390_ijms22168812 crossref_primary_10_1007_s10900_022_01141_0 crossref_primary_10_1093_tbm_ibad064 crossref_primary_10_1016_j_talanta_2025_128218 crossref_primary_10_2147_RMHP_S296914 crossref_primary_10_1093_jb_mvz105 crossref_primary_10_3389_fimmu_2022_1065379 crossref_primary_10_1016_j_amepre_2021_01_031 crossref_primary_10_1371_journal_pone_0236725 crossref_primary_10_1016_j_biopha_2022_112971 crossref_primary_10_1038_s41598_024_57604_y crossref_primary_10_3390_cancers15071984 crossref_primary_10_3390_ijms22073774 crossref_primary_10_2147_CMAR_S253174 crossref_primary_10_1155_2023_5679966 crossref_primary_10_3390_bioengineering10121424 crossref_primary_10_1016_j_ijgc_2025_101930 crossref_primary_10_1128_MCB_00363_20 crossref_primary_10_3390_cancers13184570 crossref_primary_10_1177_09622802221122390 crossref_primary_10_3390_microorganisms12112326 crossref_primary_10_1016_j_prp_2023_154729 crossref_primary_10_46879_ukroj_4_2024_478_490 crossref_primary_10_1002_jmv_29362 crossref_primary_10_1016_j_dialog_2022_100010 crossref_primary_10_3892_mmr_2021_12558 crossref_primary_10_1177_03000605241259655 crossref_primary_10_1016_j_snb_2025_137607 crossref_primary_10_2147_IJN_S234679 crossref_primary_10_3389_fonc_2021_792003 crossref_primary_10_1093_oncolo_oyaf133 crossref_primary_10_3390_ijms252211863 crossref_primary_10_1002_adfm_202213364 crossref_primary_10_3389_fmolb_2020_581615 crossref_primary_10_3892_ol_2022_13500 crossref_primary_10_3390_md21050259 crossref_primary_10_1016_j_ejrad_2021_109684 crossref_primary_10_1002_cam4_5873 crossref_primary_10_1016_j_ejphar_2022_174840 crossref_primary_10_4014_jmb_2410_10006 crossref_primary_10_32388_0GEFV4_2 crossref_primary_10_1080_15257770_2022_2160459 crossref_primary_10_1111_cas_14581 crossref_primary_10_3389_fgene_2022_923263 crossref_primary_10_3390_cancers15235625 crossref_primary_10_1038_s41417_022_00525_7 crossref_primary_10_1016_j_cej_2022_135963 crossref_primary_10_1002_hsr2_70506 crossref_primary_10_1007_s00520_021_06263_0 crossref_primary_10_1016_j_cellsig_2025_111745 crossref_primary_10_2147_IJGM_S442389 crossref_primary_10_1186_s13148_020_00885_7 crossref_primary_10_1038_s41467_021_27918_w crossref_primary_10_1111_jog_15336 crossref_primary_10_3389_fimmu_2020_01349 crossref_primary_10_1016_j_micron_2023_103520 crossref_primary_10_1186_s12913_024_10881_9 crossref_primary_10_3389_fimmu_2025_1612761 crossref_primary_10_1245_s10434_022_11583_4 crossref_primary_10_1001_jamanetworkopen_2025_10717 crossref_primary_10_3389_fonc_2021_653005 crossref_primary_10_1007_s12664_020_01069_0 crossref_primary_10_1177_10781552221139775 crossref_primary_10_1177_18758592241296277 crossref_primary_10_3390_medicina59040704 crossref_primary_10_2147_CMAR_S234897 crossref_primary_10_1002_iid3_70052 crossref_primary_10_1039_D1RA05445G crossref_primary_10_3390_healthcare11222942 crossref_primary_10_1089_cbr_2025_0031 crossref_primary_10_2147_OTT_S251926 crossref_primary_10_1016_j_canep_2023_102405 crossref_primary_10_3389_fonc_2022_979884 crossref_primary_10_1002_jssc_70083 crossref_primary_10_1016_j_canlet_2024_216809 crossref_primary_10_1186_s12885_025_14603_0 crossref_primary_10_1002_adfm_202312380 crossref_primary_10_1007_s12094_025_03852_x crossref_primary_10_1016_j_ebiom_2023_104612 crossref_primary_10_1016_j_molstruc_2024_137668 crossref_primary_10_3390_ijms24087262 crossref_primary_10_1002_ijc_34416 crossref_primary_10_3390_cancers14030575 crossref_primary_10_4103_joc_joc_170_23 crossref_primary_10_1097_MD_0000000000037153 crossref_primary_10_1158_1541_7786_MCR_22_0598 crossref_primary_10_1186_s12906_024_04357_w crossref_primary_10_1097_CAD_0000000000001278 crossref_primary_10_1109_ACCESS_2020_2972610 crossref_primary_10_3390_pharmaceutics12121185 crossref_primary_10_1111_jog_16278 crossref_primary_10_1007_s11912_020_0888_x crossref_primary_10_1158_1541_7786_MCR_22_0111 crossref_primary_10_1186_s12967_025_06409_2 crossref_primary_10_2147_CMAR_S253522 crossref_primary_10_3389_fonc_2020_584022 crossref_primary_10_2147_CMAR_S276629 crossref_primary_10_3389_fonc_2023_1100045 crossref_primary_10_1097_MD_0000000000026004 crossref_primary_10_2217_epi_2020_0437 crossref_primary_10_1142_S1088424625500506 crossref_primary_10_3390_biomedicines13010083 crossref_primary_10_2147_CMAR_S496925 crossref_primary_10_1016_j_cpt_2023_07_003 crossref_primary_10_1002_jmv_29835 crossref_primary_10_1007_s00129_021_04899_x crossref_primary_10_2196_51477 crossref_primary_10_1016_j_pdpdt_2020_101929 crossref_primary_10_2196_16467 crossref_primary_10_1186_s12885_025_13563_9 crossref_primary_10_3389_fgene_2020_00725 crossref_primary_10_1007_s12672_025_03421_2 crossref_primary_10_1007_s00404_021_06161_0 crossref_primary_10_1089_gtmb_2019_0189 crossref_primary_10_1186_s12905_022_01887_8 crossref_primary_10_1007_s00432_023_05495_3 crossref_primary_10_1080_21655979_2022_2044261 crossref_primary_10_1186_s12905_025_03848_3 crossref_primary_10_3390_cancers16111983 crossref_primary_10_1016_j_saa_2025_125923 crossref_primary_10_3389_fonc_2020_621518 crossref_primary_10_1002_ima_23043 crossref_primary_10_3390_genes12071019 crossref_primary_10_1002_cbdv_202401165 crossref_primary_10_1186_s12885_022_09582_5 crossref_primary_10_1080_21655979_2021_1921550 crossref_primary_10_1002_cam4_4860 crossref_primary_10_1186_s41747_025_00557_2 crossref_primary_10_1007_s10103_023_03930_y crossref_primary_10_1071_SH24057 crossref_primary_10_3390_ijms251910285 crossref_primary_10_1111_jcmm_15573 crossref_primary_10_1080_13880209_2024_2312217 crossref_primary_10_1155_2022_8775330 crossref_primary_10_3892_etm_2024_12671 crossref_primary_10_1590_1413_81232024293_05202023 crossref_primary_10_1016_j_joim_2019_09_004 crossref_primary_10_1038_s41598_021_93485_1 crossref_primary_10_1016_j_gene_2024_149166 crossref_primary_10_1093_eurpub_ckad055 crossref_primary_10_2147_IJGM_S354569 crossref_primary_10_3389_fonc_2025_1624111 crossref_primary_10_1007_s13167_021_00244_3 crossref_primary_10_2147_OTT_S300424 crossref_primary_10_3892_ol_2023_13921 crossref_primary_10_3389_fpubh_2024_1453704 crossref_primary_10_1038_s41598_023_35191_8 crossref_primary_10_3389_fmolb_2021_622643 crossref_primary_10_1007_s11033_022_08095_5 crossref_primary_10_1007_s12094_022_02810_1 crossref_primary_10_1186_s13048_020_00668_x crossref_primary_10_3390_diagnostics15070806 crossref_primary_10_1007_s00432_022_04446_8 crossref_primary_10_1016_j_nano_2020_102276 crossref_primary_10_1002_cam4_3780 crossref_primary_10_1002_jmv_28777 crossref_primary_10_1002_jcla_25012 crossref_primary_10_1016_j_ejogrb_2023_09_002 crossref_primary_10_1016_j_drugpo_2024_104566 crossref_primary_10_3389_fmed_2024_1370396 crossref_primary_10_1097_LGT_0000000000000668 crossref_primary_10_1038_s41467_025_57323_6 crossref_primary_10_1016_j_media_2023_103014 crossref_primary_10_1109_TRPMS_2023_3330772 crossref_primary_10_1016_j_jpba_2024_116121 crossref_primary_10_1016_j_prp_2023_154469 crossref_primary_10_1136_ijgc_2022_003370 crossref_primary_10_2147_OTT_S265007 crossref_primary_10_1016_j_humgen_2022_201048 crossref_primary_10_3390_medicina59030600 crossref_primary_10_3390_app13021061 crossref_primary_10_3389_fimmu_2024_1421778 crossref_primary_10_1186_s12905_024_03099_8 crossref_primary_10_7717_peerj_19072 crossref_primary_10_1177_17455057231164551 crossref_primary_10_1007_s00262_021_03099_9 crossref_primary_10_1016_j_tjog_2022_03_036 crossref_primary_10_1016_j_procs_2025_02_206 crossref_primary_10_1097_PGP_0000000000000975 crossref_primary_10_3390_biom12081114 crossref_primary_10_1007_s00038_020_01515_y crossref_primary_10_1016_j_ygeno_2022_110418 crossref_primary_10_1039_D3SC02782A crossref_primary_10_1002_ijc_33120 crossref_primary_10_1186_s12905_023_02713_5 crossref_primary_10_3389_fimmu_2025_1563593 crossref_primary_10_1016_j_gene_2024_149103 crossref_primary_10_1038_s41420_024_01899_3 crossref_primary_10_3390_jcm11041101 crossref_primary_10_1016_j_yexcr_2022_113052 crossref_primary_10_3389_fmed_2022_929062 crossref_primary_10_3892_ol_2022_13230 crossref_primary_10_1038_s41698_025_00948_z crossref_primary_10_2147_CMAR_S243986 crossref_primary_10_1007_s40944_020_00407_6 crossref_primary_10_1080_07391102_2023_2191719 crossref_primary_10_1155_2022_5025451 crossref_primary_10_1007_s00432_024_05809_z crossref_primary_10_7759_cureus_78115 crossref_primary_10_1038_s41598_021_86283_2 crossref_primary_10_3390_ijms23137165 crossref_primary_10_1111_1440_1681_13864 crossref_primary_10_3389_fonc_2021_698744 crossref_primary_10_52547_ajcm_28_1_42 crossref_primary_10_1111_1440_1681_13868 crossref_primary_10_1007_s00330_019_06655_1 crossref_primary_10_1007_s00432_023_05399_2 crossref_primary_10_21070_acopen_10_2025_10814 crossref_primary_10_3390_nu14010185 crossref_primary_10_1038_s41420_021_00645_3 crossref_primary_10_1007_s11010_022_04395_3 crossref_primary_10_1007_s12088_024_01295_6 crossref_primary_10_1038_s41419_019_2117_9 crossref_primary_10_3389_fchem_2025_1456743 crossref_primary_10_3389_fonc_2025_1534247 crossref_primary_10_3892_ol_2025_15021 crossref_primary_10_1016_j_stem_2021_03_012 crossref_primary_10_1136_jitc_2022_005752 crossref_primary_10_1186_s12985_023_02188_8 crossref_primary_10_1371_journal_pone_0307206 crossref_primary_10_1002_onco_13956 crossref_primary_10_1016_j_biopha_2022_114084 crossref_primary_10_3390_cancers15051620 crossref_primary_10_1007_s00330_021_08326_6 crossref_primary_10_1007_s12032_024_02433_2 crossref_primary_10_1111_jog_15163 crossref_primary_10_1186_s12889_021_12020_z crossref_primary_10_2147_IJN_S416706 crossref_primary_10_1002_jgm_3280 crossref_primary_10_1007_s12013_024_01492_6 crossref_primary_10_3389_fimmu_2024_1334829 crossref_primary_10_1136_ijgc_2020_001840 crossref_primary_10_1016_j_coviro_2021_10_010 crossref_primary_10_3389_fonc_2021_672386 crossref_primary_10_1007_s10495_023_01812_w crossref_primary_10_1002_jmv_27478 crossref_primary_10_1002_mco2_368 crossref_primary_10_3390_pathogens9040292 crossref_primary_10_1186_s13643_021_01740_3 crossref_primary_10_1002_ijc_33380 crossref_primary_10_12677_NS_2023_125113 crossref_primary_10_1016_j_nantod_2025_102692 crossref_primary_10_1016_j_bioorg_2025_108361 crossref_primary_10_1016_j_prp_2023_154673 crossref_primary_10_1002_bab_2667 crossref_primary_10_3389_fonc_2023_1174470 crossref_primary_10_1016_j_medp_2024_100058 crossref_primary_10_1007_s13577_021_00654_5 crossref_primary_10_1016_j_ijrobp_2020_11_052 crossref_primary_10_3389_fendo_2023_1280631 crossref_primary_10_3389_fmed_2021_693567 crossref_primary_10_1186_s40249_023_01139_3 crossref_primary_10_1016_j_intimp_2020_106935 crossref_primary_10_1097_CAD_0000000000001085 crossref_primary_10_1109_TBME_2020_3019755 crossref_primary_10_1038_s41598_024_84203_8 crossref_primary_10_1093_intqhc_mzad024 crossref_primary_10_1007_s13273_024_00467_1 crossref_primary_10_1016_j_modpat_2024_100486 crossref_primary_10_1088_2057_1976_ad403a crossref_primary_10_1172_JCI177599 crossref_primary_10_1186_s12905_023_02702_8 crossref_primary_10_1007_s00432_024_05773_8 crossref_primary_10_1186_s12884_021_03766_w crossref_primary_10_1038_s41598_025_12450_4 crossref_primary_10_1111_jep_14074 crossref_primary_10_1155_2021_6645885 crossref_primary_10_1158_1541_7786_MCR_23_0478 crossref_primary_10_1016_j_bpobgyn_2021_01_013 crossref_primary_10_3390_jpm13050733 crossref_primary_10_1038_s41598_021_98527_2 crossref_primary_10_1016_j_tvr_2025_200323 crossref_primary_10_3390_cancers11111782 crossref_primary_10_1016_j_lfs_2020_118814 crossref_primary_10_1080_01443615_2023_2179915 crossref_primary_10_2196_49558 crossref_primary_10_1155_2022_4364663 crossref_primary_10_1186_s12915_024_01876_3 crossref_primary_10_7759_cureus_54106 crossref_primary_10_1016_j_tranon_2025_102396 crossref_primary_10_46879_ukroj_1_2024_44_55 crossref_primary_10_1186_s13046_020_01737_1 crossref_primary_10_1007_s10096_024_04963_z crossref_primary_10_1016_j_semcancer_2024_11_002 crossref_primary_10_1109_JPHOT_2021_3075958 crossref_primary_10_1042_BSR20204457 crossref_primary_10_3390_bioengineering9120740 crossref_primary_10_1093_hmg_ddac130 crossref_primary_10_1038_s41598_022_16361_6 crossref_primary_10_3389_fonc_2025_1511748 crossref_primary_10_1016_j_acra_2022_08_002 crossref_primary_10_1016_j_rsma_2022_102619 crossref_primary_10_3892_ol_2021_13007 crossref_primary_10_1007_s12672_022_00494_1 crossref_primary_10_1016_j_tice_2023_102151 crossref_primary_10_1186_s12885_021_08531_y crossref_primary_10_3390_cancers15082390 crossref_primary_10_1016_j_yfpn_2021_01_009 crossref_primary_10_3389_fimmu_2025_1627235 crossref_primary_10_26453_otjhs_842600 crossref_primary_10_3390_vaccines11010139 crossref_primary_10_1007_s12033_025_01482_w crossref_primary_10_1097_LGT_0000000000000806 crossref_primary_10_1136_ijgc_2020_001254 crossref_primary_10_1016_j_semradonc_2020_05_010 crossref_primary_10_1016_j_prp_2024_155612 crossref_primary_10_1016_j_prp_2024_155611 crossref_primary_10_1080_15384047_2024_2349429 crossref_primary_10_1186_s13014_024_02569_5 crossref_primary_10_1158_1541_7786_MCR_20_0639 crossref_primary_10_1016_j_prenap_2025_100272 crossref_primary_10_1093_lambio_ovaf088 crossref_primary_10_1016_j_isci_2024_110155 crossref_primary_10_1016_j_ygyno_2020_10_011 crossref_primary_10_1002_ijc_35369 crossref_primary_10_1002_ijgo_15577 crossref_primary_10_1007_s10147_021_02037_0 crossref_primary_10_1007_s00216_021_03431_3 crossref_primary_10_1186_s12985_022_01929_5 crossref_primary_10_3389_fimmu_2024_1459693 crossref_primary_10_2147_CIA_S255305 crossref_primary_10_1016_j_ygyno_2021_08_031 crossref_primary_10_1093_carcin_bgad039 crossref_primary_10_3389_fonc_2022_1043937 crossref_primary_10_1038_s41598_024_82074_7 crossref_primary_10_3390_pharmaceutics15020349 crossref_primary_10_1016_j_gore_2024_101437 crossref_primary_10_1016_j_compbiomed_2023_107581 crossref_primary_10_1186_s12885_024_12872_9 crossref_primary_10_1097_CAD_0000000000001214 crossref_primary_10_1016_j_aca_2021_338693 crossref_primary_10_3389_fonc_2021_774459 crossref_primary_10_3390_diagnostics13081382 crossref_primary_10_1371_journal_pone_0329007 crossref_primary_10_3390_jcm12185992 crossref_primary_10_1124_pharmrev_122_000801 crossref_primary_10_1159_000542833 crossref_primary_10_1155_2022_9109365 crossref_primary_10_1186_s12985_025_02783_x crossref_primary_10_1016_j_ejmech_2022_114271 crossref_primary_10_3389_fphar_2024_1399885 crossref_primary_10_1016_j_ygyno_2021_08_029 crossref_primary_10_1039_D0RA09155C crossref_primary_10_1186_s12859_021_04261_x crossref_primary_10_1186_s12905_023_02844_9 crossref_primary_10_1016_j_clim_2021_108684 crossref_primary_10_1097_MD_0000000000020558 crossref_primary_10_3390_cancers15020546 crossref_primary_10_1016_j_bmcl_2022_128916 crossref_primary_10_1186_s12885_024_13079_8 crossref_primary_10_1016_j_tranon_2025_102363 crossref_primary_10_1016_S1470_2045_19_30409_7 crossref_primary_10_1155_2022_5262963 crossref_primary_10_3390_cancers15051419 crossref_primary_10_1007_s40944_025_01013_0 crossref_primary_10_4103_jcrt_JCRT_1346_20 crossref_primary_10_1186_s13073_022_01116_9 crossref_primary_10_3892_ol_2021_13033 crossref_primary_10_1016_j_biopha_2019_109135 crossref_primary_10_1128_msphere_00427_23 crossref_primary_10_1186_s12912_025_03571_2 crossref_primary_10_3390_s25092826 crossref_primary_10_1007_s12672_024_00964_8 crossref_primary_10_1016_j_annepidem_2022_08_052 crossref_primary_10_1002_hsr2_2149 crossref_primary_10_1186_s12905_023_02853_8 crossref_primary_10_4103_npmj_npmj_265_24 crossref_primary_10_1186_s12905_024_03024_z crossref_primary_10_1590_1413_81232024293_05202023en crossref_primary_10_1016_j_ogrm_2023_11_001 crossref_primary_10_1007_s11010_021_04306_y crossref_primary_10_1186_s12885_023_10808_3 crossref_primary_10_3389_fonc_2022_847974 crossref_primary_10_1111_febs_16331 crossref_primary_10_1155_2021_6677687 crossref_primary_10_3389_fonc_2025_1640418 crossref_primary_10_1007_s12013_020_00904_7 crossref_primary_10_1186_s12957_021_02384_2 crossref_primary_10_1002_iub_2706 crossref_primary_10_1007_s00129_019_04534_w crossref_primary_10_1002_cam4_7245 crossref_primary_10_1002_hed_27603 crossref_primary_10_1186_s13148_022_01353_0 crossref_primary_10_1200_GO_22_00183 crossref_primary_10_7759_cureus_87492 crossref_primary_10_1038_s41467_022_31719_0 crossref_primary_10_20862_0042_4676_2025_106_1_3_6_16 crossref_primary_10_1136_ijgc_2023_004589 crossref_primary_10_1038_s41598_022_17632_y crossref_primary_10_1002_jcla_24348 crossref_primary_10_3390_electronics14102014 crossref_primary_10_2147_CMAR_S272478 crossref_primary_10_3390_bios14010034 crossref_primary_10_3390_cancers16142496 crossref_primary_10_12998_wjcc_v13_i2_100198 crossref_primary_10_3390_cancers15164068 crossref_primary_10_1186_s12885_024_12314_6 crossref_primary_10_1016_j_cmi_2025_07_004 crossref_primary_10_1016_j_gore_2022_101069 crossref_primary_10_1002_jmv_70454 crossref_primary_10_18502_ijrm_v21i10_14536 crossref_primary_10_3390_biom10060857 crossref_primary_10_1016_j_jep_2022_116062 crossref_primary_10_1177_20587384211016131 crossref_primary_10_1002_jmv_28717 crossref_primary_10_1097_GCO_0000000000000598 crossref_primary_10_1155_2022_6207701 crossref_primary_10_1016_j_meegid_2025_105746 crossref_primary_10_1088_1748_605X_ad4246 crossref_primary_10_1007_s13187_025_02677_0 crossref_primary_10_1089_rej_2022_0009 crossref_primary_10_1097_LGT_0000000000000853 crossref_primary_10_1080_01443615_2024_2333784 crossref_primary_10_3390_v16040642 crossref_primary_10_1002_tbio_202200006 crossref_primary_10_1039_D5TB00625B crossref_primary_10_1016_j_gene_2019_143961 crossref_primary_10_1089_gtmb_2021_0006 crossref_primary_10_3389_fonc_2021_720447 crossref_primary_10_1007_s00432_024_05973_2 crossref_primary_10_3389_fonc_2024_1347727 crossref_primary_10_1208_s12249_019_1393_0 crossref_primary_10_3389_fonc_2023_1235035 crossref_primary_10_1007_s00432_023_05514_3 crossref_primary_10_1007_s12672_025_02973_7 crossref_primary_10_1097_CEJ_0000000000000849 crossref_primary_10_3390_jpm12050755 crossref_primary_10_1007_s13577_021_00650_9 crossref_primary_10_3390_cancers15020509 crossref_primary_10_1002_cam4_6179 crossref_primary_10_1016_j_colsurfb_2020_111270 crossref_primary_10_1155_2022_1056825 crossref_primary_10_3390_v15122314 crossref_primary_10_3389_fonc_2021_753102 crossref_primary_10_1371_journal_pone_0261203 crossref_primary_10_1177_03000605241233966 crossref_primary_10_1016_j_compbiomed_2023_107151 crossref_primary_10_1590_0034_7167_2021_0874
Cites_doi	10.1056/NEJMoa1804923 10.1006/gyno.1999.5387 10.1016/j.ygyno.2010.12.345 10.1093/annonc/mdy160 10.1016/S1470-2045(16)30032-8 10.1111/IGC.0b013e3181a130f3 10.3399/bjgp14X681757 10.1038/ncponc0822 10.1016/S0140-6736(17)32513-8 10.1186/1471-2407-14-207 10.1371/journal.pone.0185332 10.1200/JCO.2014.58.4391 10.1097/CCO.0000000000000309 10.1038/bjc.2012.351 10.1200/JCO.2017.35.15_suppl.5504 10.1001/jamaoncol.2017.5179 10.1016/j.ygyno.2004.12.007 10.1097/IGC.0b013e3182a80a65 10.1016/S2214-109X(18)30082-2 10.1200/JCO.2014.58.9093 10.1016/S0140-6736(17)31607-0 10.1002/cncr.30667 10.1002/ijc.22114 10.1016/j.ygyno.2010.12.352 10.1016/S0140-6736(13)60022-7 10.1097/IGC.0000000000000207 10.1007/s00428-018-2362-9 10.1016/j.ijrobp.2013.05.033 10.1097/IGC.0000000000000780 10.1016/S0140-6736(11)60551-5 10.1002/ijc.31610 10.1002/cncr.10207 10.1245/s10434-010-0985-4 10.1200/JCO.2000.18.8.1606 10.1016/j.vaccine.2009.04.041 10.1016/j.ejca.2013.04.024 10.7314/APJCP.2014.15.22.10003 10.1016/S1470-2045(08)70074-3 10.1200/JCO.2017.75.9985 10.1503/cmaj.071124 10.1245/s10434-014-4344-8 10.1016/S1473-3099(14)71073-4 10.1200/JCO.2018.36.15_suppl.5522 10.1055/s-2007-986680 10.1086/421467 10.1200/JGO.2016.004895 10.1200/JCO.2017.77.4273 10.1186/1477-7819-12-279 10.1016/j.ygyno.2006.08.009 10.1016/j.gore.2017.07.009 10.1097/IGC.0000000000000587 10.1016/S0140-6736(07)61050-2 10.1016/S0140-6736(13)62218-7 10.1038/nature21386 10.1016/j.ajog.2016.04.023 10.3747/co.23.2742 10.1056/NEJMoa1806395 10.1016/j.radonc.2012.04.007 10.1016/S0140-6736(03)13778-6 10.1002/ijc.28666 10.1016/j.ygyno.2005.07.071 10.1186/1757-2215-7-69 10.1016/j.vaccine.2018.03.045 10.1016/j.ygyno.2015.03.051 10.1016/j.ijrobp.2010.04.041 10.1016/j.ygyno.2006.05.044 10.1016/0090-8258(92)90310-F 10.1097/IGC.0b013e318295906b 10.1016/j.ygyno.2014.06.034 10.1006/gyno.1996.0268 10.1016/j.ijgo.2009.08.009 10.1093/fampra/cmr033 10.1016/S0090-8258(89)80024-1 10.1200/JCO.2005.02.0354 10.1111/IGC.0b013e3181da29d0 10.1016/S0360-3016(98)00482-9 10.1200/JCO.2018.78.8893 10.1016/j.ijrobp.2013.06.2059 10.1016/S0020-7292(00)90001-8 10.1016/j.ygyno.2015.06.009 10.1001/jama.2018.7464 10.1016/S1470-2045(18)30003-2 10.1056/NEJM199904153401502 10.1016/j.ygyno.2018.04.022 10.1006/gyno.1995.0022 10.1016/j.ijrobp.2004.01.034 10.1200/JCO.2009.25.9663 10.2105/AJPH.2011.300532 10.1002/(SICI)1097-0142(20000415)88:8<1877::AID-CNCR17>3.0.CO;2-W 10.1016/S1470-2045(07)70341-8 10.1016/j.ygyno.2003.11.020 10.1016/S0140-6736(17)31821-4 10.1016/S0140-6736(97)02250-2 10.1016/0090-8258(90)90072-S 10.1200/jco.2014.32.15_suppl.tps5632 10.1056/NEJM199904153401503 10.1002/ijc.22357 10.1016/j.ygyno.2017.03.022
ContentType	Journal Article
Copyright	2019 Elsevier Ltd Copyright © 2019 Elsevier Ltd. All rights reserved. 2019. Elsevier Ltd
Copyright_xml	– notice: 2019 Elsevier Ltd – notice: Copyright © 2019 Elsevier Ltd. All rights reserved. – notice: 2019. Elsevier Ltd
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7RV 7TK 7U7 7U9 7X7 7XB 88A 88C 88E 88G 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AN0 ASE AZQEC BBNVY BEC BENPR BHPHI C1K CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K6X K9- K9. KB0 KB~ LK8 M0R M0S M0T M1P M2M M2O M2P M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U S0X 7X8
DOI	10.1016/S0140-6736(18)32470-X
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database Lancet Titles ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland British Nursing Database British Nursing Index ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection British Nursing Index Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Newsstand Professional Biological Sciences Consumer Health Database ProQuest Health & Medical Collection Healthcare Administration Database Medical Database PsycINFO Research Library Science Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic SIRS Editorial MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest Central Essentials Lancet Titles elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Newsstand Professional Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic Toxicology Abstracts ProQuest Science Journals British Nursing Index with Full Text ProQuest Health Management British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection ProQuest Medical Library ProQuest Psychology Journals ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE ProQuest One Psychology MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1474-547X
EndPage	182
ExternalDocumentID	30638582 10_1016_S0140_6736_18_32470_X S014067361832470X
Genre	Journal Article Review
GeographicLocations	United States--US South Africa Africa
GeographicLocations_xml	– name: South Africa – name: Africa – name: United States--US
GroupedDBID	--- --K --M .1- .55 .CO .FO 0R~ 123 1B1 1P~ 1RT 1~5 29L 4.4 457 4G. 53G 5VS 7-5 71M 7RV 7X7 88E 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8G5 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAMRU AAQFI AAQQT AATTM AAXKI AAXUO AAYWO ABBQC ABCQX ABFNM ABIVO ABJNI ABLJU ABMAC ABMZM ABOCM ABUFD ABUWG ACGFS ACGOD ACIEU ACIUM ACLOT ACPRK ACRLP ACVFH ADBBV ADCNI AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGAPS AGHFR AHMBA AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AN0 ANZVX APXCP AQUVI AXJTR AZQEC BBNVY BCU BEC BENPR BHPHI BKEYQ BKNYI BKOJK BKOMP BNPGV BNQBC BPHCQ BVXVI CCPQU CS3 DU5 DWQXO EAU EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EWM EX3 F5P FD8 FDB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K-O K9- KOM L7B LK8 LZ2 M0R M0T M1P M2M M2O M2P M7P MJL MO0 N9A NAPCQ O-L O9- OD. OO~ OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PRG PROAC PSQYO PSYQQ ROL RPZ S0X SAD SDG SEL SES SJFOW SJN SPCBC SSH SSZ T5K TLN TWZ UAP UBE UKHRP UV1 WOW X7M XAX XDU YYM Z5R ZMT ~HD 04C 3V. 88A AACTN ABLVK ABYKQ AFKWA AJOXV AMFUW M0L M41 RIG SDF XFK ZA5 .GJ 3EH 3O- 41~ 8WZ 9DU A6W AAEJM AAKAS AAQXK AAYXX ABDBF ABWVN ACRPL ACUHS ADMUD ADNMO ADXHL ADZCM AFFHD AFFNX AGQPQ AHHHB AHQJS AIGII AJJEV AKVCP ARTTT ASPBG AVWKF AZFZN CITATION D0S EAP EAS EAZ EBC EBD EBU EGS EHN EIHBH EMB EMK EMOBN ENC EPL EPS EPT ESX EVS FEDTE FGOYB HVGLF HZ~ J5H MVM OVD Q~Q R2- SV3 TEORI TH9 UHU UQL WOQ WUQ XPP YYQ ZGI ZXP ZY4 ~G0 AFCTW ALIPV CGR CUY CVF ECM EIF NPM 7QL 7QP 7TK 7U7 7U9 7XB 8FK ASE C1K FPQ H94 K6X K9. KB~ M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO
ID	FETCH-LOGICAL-c447t-fc1b07e978c0dec7426c2fa149dc99434d76dd27ea916dd042ce7f15b041820c3
IEDL.DBID	7RV
ISICitedReferencesCount	1863
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000455437100030&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0140-6736 1474-547X
IngestDate	Sat Sep 27 17:21:01 EDT 2025 Tue Oct 07 07:05:04 EDT 2025 Wed Feb 19 02:35:12 EST 2025 Tue Nov 18 22:41:08 EST 2025 Sat Nov 29 07:26:20 EST 2025 Fri Feb 23 02:27:24 EST 2024 Tue Oct 14 19:29:46 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	10167
Language	English
License	Copyright © 2019 Elsevier Ltd. All rights reserved.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c447t-fc1b07e978c0dec7426c2fa149dc99434d76dd27ea916dd042ce7f15b041820c3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23
PMID	30638582
PQID	2166090092
PQPubID	40246
PageCount	14
ParticipantIDs	proquest_miscellaneous_2179324728 proquest_journals_2166090092 pubmed_primary_30638582 crossref_primary_10_1016_S0140_6736_18_32470_X crossref_citationtrail_10_1016_S0140_6736_18_32470_X elsevier_sciencedirect_doi_10_1016_S0140_6736_18_32470_X elsevier_clinicalkey_doi_10_1016_S0140_6736_18_32470_X
PublicationCentury	2000
PublicationDate	2019-01-12
PublicationDateYYYYMMDD	2019-01-12
PublicationDate_xml	– month: 01 year: 2019 text: 2019-01-12 day: 12
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England – name: London
PublicationTitle	The Lancet (British edition)
PublicationTitleAlternate	Lancet
PublicationYear	2019
Publisher	Elsevier Ltd Elsevier Limited
Publisher_xml	– name: Elsevier Ltd – name: Elsevier Limited
References	Crosbie, Einstein, Franceschi, Kitchener (bib20) 2013; 382 Magrina, Goodrich, Weaver, Podratz (bib52) 1995; 59 Shazly, Murad, Dowdy, Gostout, Famuyide (bib70) 2015; 138 Sedlis, Bundy, Rotman, Lentz, Muderspach, Zaino (bib74) 1999; 73 Buckley, Tritz, Van Le (bib47) 1996; 63 Westin, Rallapalli, Fellman (bib94) 2014; 134 Duenas-Gonzalez, Zarba, Patel (bib90) 2011; 29 Plante, Amant (bib63) Bray, Ferlay, Soerjomataram, Siegel, Torre, Jemal (bib1) 2018; 68 Peters, Liu, Barrett (bib75) 2000; 18 Logsdon, Eifel (bib83) 1999; 43 Hollebecque, Meyer, Moore (bib108) 2017; 35 (bib2) 2018 Sriplung, Singkham, Iamsirithaworn, Jiraphongsa, Bilheem (bib9) 2014; 15 Benedet, Bender, Jones, Ngan, Pecorelli (bib36) 2000; 70 Maciag, Radulovic, Rothman (bib109) 2009; 27 Cibula, Potter, Planchamp (bib6) 2018; 472 Boss, van Golde, Beerendonk, Massuger (bib61) 2005; 99 Melamed, Margul, Chen (bib72) 2018; 379 Knaul, Farmer, Krakauer (bib117) 2018; 391 bib106 Donovan, Taliaferro, Alvarez, Jacobsen, Roetzheim, Wenham (bib65) 2007; 104 Kokka, Bryant, Brockbank, Powell, Oram (bib69) 2015; 4 Small, Bacon, Bajaj (bib4) 2017; 123 Copeland, Silva, Gershenson, Morris, Young, Wharton (bib45) 1992; 45 Shrivastava, Mahantshetty, Engineer (bib82) 2018; 4 Carlson, Kauderer, Hutson (bib101) 2018; 149 Bentivegna, Gouy, Maulard, Chargari, Leary, Morice (bib58) 2016; 17 (bib115) 2017; 543 Edge, Compton (bib38) 2010; 17 Gyawali, Iddawela (bib105) 2017; 3 Hasselle, Rose, Kochanski (bib111) 2011; 80 Lee, Wang, Lin (bib76) 1989; 32 Abu-Rustum, Sonoda, Black, Levine, Chi, Barakat (bib56) 2006; 103 Querleu, Morrow (bib49) 2008; 9 Hareyama, Sakata, Oouchi (bib85) 2002; 94 Pieterse, Kenter, Maas (bib64) 2013; 23 Mileshkin, Narayan, Moore (bib91) 2014; 32 Piver, Rutledge, Smith (bib48) 1974; 44 Ronco, Dillner, Elfström (bib30) 2014; 383 Hall, Simms, Lew, Smith, Saville, Canfell (bib25) 2018; 13 (bib7) 2016 Chen, Wang, Zhang (bib66) 2016; 215 Ye, Yang, Cao, Lang, Shen (bib99) 2014; 24 Crosbie, Einstein, Franceschi, Kitchener (bib3) 2013; 382 Ogilvie, van Niekerk, Krajden (bib31) 2018; 320 Plante (bib55) 2013; 23 Pareja, Rendon, Vasquez, Echeverri, Sanz-Lomana, Ramirez (bib54) 2015; 137 Salani, Khanna, Frimer, Bristow, Chen (bib97) 2017; 146 Han, Milosevic, Fyles, Pintilie, Viswanathan (bib86) 2013; 87 Andreyev (bib100) 2007; 8 Bos, Rebolj, Habbema, van Ballegooijen (bib17) 2006; 119 Rose, Bundy, Watkins (bib80) 1999; 340 Roura, Castellsagué, Pawlita (bib19) 2014; 135 Brotherton, Fridman, May, Chappell, Saville, Gertig (bib26) 2011; 377 Tewari, Sill, Penson (bib104) 2017; 390 Stapley, Hamilton (bib33) 2011; 28 Gubbala, Laios, Gallos, Pathiraja, Haldar, Ind (bib68) 2014; 7 Olorunfemi, Ndlovu, Masukume, Chikandiwa, Pisa, Singh (bib12) 2018; 143 Fedewa, Cokkinides, Virgo, Bandi, Saslow, Ward (bib13) 2012; 102 Huh, Joura, Giuliano (bib24) 2017; 390 Sivaram, Majumdar, Perin (bib32) 2018; 19 Sagae, Monk, Pujade-Lauraine (bib113) 2016; 26 Crosbie, Einstein, Franceschi, Kitchener (bib14) 2013; 382 Schmeler, Frumovitz, Ramirez (bib53) 2011; 120 Dargent, Martin, Sacchetoni, Mathevet (bib57) 2000; 88 Ramirez, Frumovitz, Pareja (bib71) 2018; 379 Waggoner (bib11) 2003; 361 Zanagnolo, Minig, Gadducci (bib98) 2009; 19 Jolley, Battista, Wing (bib62) 2007; 24 Knaul, Bhadelia, Rodriguez, Arreola-Ornelas, Zimmermann (bib118) 2018; 6 (bib15) 2007; 120 Keys, Bundy, Stehman (bib79) 1999; 340 Grulich, van Leeuwen, Falster, Vajdic (bib16) 2007; 370 Gandhi, Sharma, Rath (bib112) 2013; 87 Creasman, Kohler (bib77) 2004; 92 Halaska, Novackova, Mala (bib51) 2010; 20 Vaccarella, Lortet-Tieulent, Plummer, Franceschi, Bray (bib8) 2013; 49 Landoni, Maneo, Colombo (bib50) 1997; 350 Klopp, Yeung, Deshmukh (bib114) 2018; 36 Chung, Schellens, Delord (bib107) 2018; 36 Rajaram, Chitrathara, Maheshwari (bib35) 2012 Marth, Landoni, Mahner, McCormack, Gonzalez-Martin, Colombo (bib39) 2018; 29 Denny (bib29) 2015; 22 Havrilesky, Kulasingam, Matchar, Myers (bib42) 2005; 97 Quinn, Benedet, Odicino (bib44) 2006; 95 Ghebre, Grover, Xu, Chuang, Simonds (bib23) 2017; 21 Moscicki, Ellenberg, Farhat, Xu (bib22) 2018; 190 Brockbank, Kokka, Bryant, Pomel, Reynolds (bib40) 2013; 3 Lertsanguansinchai, Lertbutsayanukul, Shotelersuk (bib84) 2004; 59 Selman, Mann, Zamora, Appleyard, Khan (bib41) 2008; 178 Lim, Ramirez, Hamilton, Sasieni, Patnick, Forbes (bib34) 2014; 64 bib95 Castelnau-Marchand, Chargari, Haie-Meder, Mazeron (bib87) 2016; 28 (bib81) 2010; 1 Jiao, Hu, Zhu (bib67) 2016; 26 Delgado, Bundy, Zaino, Sevin, Creasman, Major (bib73) 1990; 38 Kitagawa, Katsumata, Shibata (bib103) 2015; 33 Hricak, Gatsonis, Chi (bib43) 2005; 23 Drolet, Bénard, Boily (bib27) 2015; 15 Godinho, Wulfkuhle, Look (bib116) 2012; 107 Gargano, Zhou, Stokley, Markowitz (bib28) 2018; 36 Gupta, Maheshwari, Parab (bib92) 2018; 36 Stevanovic, Draper, Langhan (bib110) 2015; 33 Potter, Tanderup, Kirisits (bib89) 2018; 9 Torre, Bray, Siegel, Ferlay, Lortet-Tieulent, Jemal (bib10) 2015; 65 Elit, Kennedy, Fyles, Metser (bib96) 2016; 23 bib21 Beiner, Covens (bib59) 2007; 4 (bib46) 2018 Kasuya, Ogawa, Iraha (bib78) 2013; 33 Pecorelli (bib37) 2010; 108 Plante, Gregoire, Renaud, Roy (bib60) 2011; 121 Charra-Brunaud, Harter, Delannes (bib88) 2012; 103 Zou, Hu, Feng, Wang (bib93) 2018; 36 Petruzziello, Kondo, Hatschback (bib102) 2014; 12 Ries, Melbert, Krapcho (bib5) 2007 Sultana, English, Simpson (bib18) 2014; 14 Carlson (10.1016/S0140-6736(18)32470-X_bib101) 2018; 149 Abu-Rustum (10.1016/S0140-6736(18)32470-X_bib56) 2006; 103 Brotherton (10.1016/S0140-6736(18)32470-X_bib26) 2011; 377 Hricak (10.1016/S0140-6736(18)32470-X_bib43) 2005; 23 Beiner (10.1016/S0140-6736(18)32470-X_bib59) 2007; 4 Castelnau-Marchand (10.1016/S0140-6736(18)32470-X_bib87) 2016; 28 Jolley (10.1016/S0140-6736(18)32470-X_bib62) 2007; 24 (10.1016/S0140-6736(18)32470-X_bib81) 2010; 1 Shazly (10.1016/S0140-6736(18)32470-X_bib70) 2015; 138 Kokka (10.1016/S0140-6736(18)32470-X_bib69) 2015; 4 Lee (10.1016/S0140-6736(18)32470-X_bib76) 1989; 32 Kasuya (10.1016/S0140-6736(18)32470-X_bib78) 2013; 33 Gupta (10.1016/S0140-6736(18)32470-X_bib92) 2018; 36 Querleu (10.1016/S0140-6736(18)32470-X_bib49) 2008; 9 Magrina (10.1016/S0140-6736(18)32470-X_bib52) 1995; 59 Han (10.1016/S0140-6736(18)32470-X_bib86) 2013; 87 Jiao (10.1016/S0140-6736(18)32470-X_bib67) 2016; 26 Pieterse (10.1016/S0140-6736(18)32470-X_bib64) 2013; 23 Plante (10.1016/S0140-6736(18)32470-X_bib55) 2013; 23 Sriplung (10.1016/S0140-6736(18)32470-X_bib9) 2014; 15 Stevanovic (10.1016/S0140-6736(18)32470-X_bib110) 2015; 33 Torre (10.1016/S0140-6736(18)32470-X_bib10) 2015; 65 Ghebre (10.1016/S0140-6736(18)32470-X_bib23) 2017; 21 Stapley (10.1016/S0140-6736(18)32470-X_bib33) 2011; 28 Potter (10.1016/S0140-6736(18)32470-X_bib89) 2018; 9 Lim (10.1016/S0140-6736(18)32470-X_bib34) 2014; 64 Roura (10.1016/S0140-6736(18)32470-X_bib19) 2014; 135 Drolet (10.1016/S0140-6736(18)32470-X_bib27) 2015; 15 Hall (10.1016/S0140-6736(18)32470-X_bib25) 2018; 13 Lertsanguansinchai (10.1016/S0140-6736(18)32470-X_bib84) 2004; 59 Knaul (10.1016/S0140-6736(18)32470-X_bib117) 2018; 391 Halaska (10.1016/S0140-6736(18)32470-X_bib51) 2010; 20 Zou (10.1016/S0140-6736(18)32470-X_bib93) 2018; 36 Knaul (10.1016/S0140-6736(18)32470-X_bib118) 2018; 6 Schmeler (10.1016/S0140-6736(18)32470-X_bib53) 2011; 120 Charra-Brunaud (10.1016/S0140-6736(18)32470-X_bib88) 2012; 103 Crosbie (10.1016/S0140-6736(18)32470-X_bib20) 2013; 382 Bos (10.1016/S0140-6736(18)32470-X_bib17) 2006; 119 Boss (10.1016/S0140-6736(18)32470-X_bib61) 2005; 99 Gargano (10.1016/S0140-6736(18)32470-X_bib28) 2018; 36 Godinho (10.1016/S0140-6736(18)32470-X_bib116) 2012; 107 Denny (10.1016/S0140-6736(18)32470-X_bib29) 2015; 22 Havrilesky (10.1016/S0140-6736(18)32470-X_bib42) 2005; 97 Gubbala (10.1016/S0140-6736(18)32470-X_bib68) 2014; 7 Duenas-Gonzalez (10.1016/S0140-6736(18)32470-X_bib90) 2011; 29 Sultana (10.1016/S0140-6736(18)32470-X_bib18) 2014; 14 Rajaram (10.1016/S0140-6736(18)32470-X_bib35) 2012 Cibula (10.1016/S0140-6736(18)32470-X_bib6) 2018; 472 Benedet (10.1016/S0140-6736(18)32470-X_bib36) 2000; 70 Andreyev (10.1016/S0140-6736(18)32470-X_bib100) 2007; 8 Pecorelli (10.1016/S0140-6736(18)32470-X_bib37) 2010; 108 Waggoner (10.1016/S0140-6736(18)32470-X_bib11) 2003; 361 Selman (10.1016/S0140-6736(18)32470-X_bib41) 2008; 178 Shrivastava (10.1016/S0140-6736(18)32470-X_bib82) 2018; 4 Small (10.1016/S0140-6736(18)32470-X_bib4) 2017; 123 Plante (10.1016/S0140-6736(18)32470-X_bib60) 2011; 121 Ramirez (10.1016/S0140-6736(18)32470-X_bib71) 2018; 379 Logsdon (10.1016/S0140-6736(18)32470-X_bib83) 1999; 43 Delgado (10.1016/S0140-6736(18)32470-X_bib73) 1990; 38 Peters (10.1016/S0140-6736(18)32470-X_bib75) 2000; 18 Pareja (10.1016/S0140-6736(18)32470-X_bib54) 2015; 137 Vaccarella (10.1016/S0140-6736(18)32470-X_bib8) 2013; 49 Bentivegna (10.1016/S0140-6736(18)32470-X_bib58) 2016; 17 Kitagawa (10.1016/S0140-6736(18)32470-X_bib103) 2015; 33 Ogilvie (10.1016/S0140-6736(18)32470-X_bib31) 2018; 320 Mileshkin (10.1016/S0140-6736(18)32470-X_bib91) 2014; 32 Westin (10.1016/S0140-6736(18)32470-X_bib94) 2014; 134 Salani (10.1016/S0140-6736(18)32470-X_bib97) 2017; 146 Crosbie (10.1016/S0140-6736(18)32470-X_bib14) 2013; 382 Moscicki (10.1016/S0140-6736(18)32470-X_bib22) 2018; 190 (10.1016/S0140-6736(18)32470-X_bib7) 2016 Donovan (10.1016/S0140-6736(18)32470-X_bib65) 2007; 104 (10.1016/S0140-6736(18)32470-X_bib15) 2007; 120 Copeland (10.1016/S0140-6736(18)32470-X_bib45) 1992; 45 Marth (10.1016/S0140-6736(18)32470-X_bib39) 2018; 29 Klopp (10.1016/S0140-6736(18)32470-X_bib114) 2018; 36 Petruzziello (10.1016/S0140-6736(18)32470-X_bib102) 2014; 12 Rose (10.1016/S0140-6736(18)32470-X_bib80) 1999; 340 Hasselle (10.1016/S0140-6736(18)32470-X_bib111) 2011; 80 Buckley (10.1016/S0140-6736(18)32470-X_bib47) 1996; 63 Hollebecque (10.1016/S0140-6736(18)32470-X_bib108) 2017; 35 Sedlis (10.1016/S0140-6736(18)32470-X_bib74) 1999; 73 Sagae (10.1016/S0140-6736(18)32470-X_bib113) 2016; 26 Crosbie (10.1016/S0140-6736(18)32470-X_bib3) 2013; 382 Fedewa (10.1016/S0140-6736(18)32470-X_bib13) 2012; 102 (10.1016/S0140-6736(18)32470-X_bib115) 2017; 543 Olorunfemi (10.1016/S0140-6736(18)32470-X_bib12) 2018; 143 Chung (10.1016/S0140-6736(18)32470-X_bib107) 2018; 36 Ronco (10.1016/S0140-6736(18)32470-X_bib30) 2014; 383 Gandhi (10.1016/S0140-6736(18)32470-X_bib112) 2013; 87 Edge (10.1016/S0140-6736(18)32470-X_bib38) 2010; 17 Hareyama (10.1016/S0140-6736(18)32470-X_bib85) 2002; 94 Bray (10.1016/S0140-6736(18)32470-X_bib1) 2018; 68 Sivaram (10.1016/S0140-6736(18)32470-X_bib32) 2018; 19 Keys (10.1016/S0140-6736(18)32470-X_bib79) 1999; 340 Gyawali (10.1016/S0140-6736(18)32470-X_bib105) 2017; 3 Brockbank (10.1016/S0140-6736(18)32470-X_bib40) 2013; 3 Tewari (10.1016/S0140-6736(18)32470-X_bib104) 2017; 390 Chen (10.1016/S0140-6736(18)32470-X_bib66) 2016; 215 Maciag (10.1016/S0140-6736(18)32470-X_bib109) 2009; 27 Elit (10.1016/S0140-6736(18)32470-X_bib96) 2016; 23 Ye (10.1016/S0140-6736(18)32470-X_bib99) 2014; 24 Landoni (10.1016/S0140-6736(18)32470-X_bib50) 1997; 350 Creasman (10.1016/S0140-6736(18)32470-X_bib77) 2004; 92 Plante (10.1016/S0140-6736(18)32470-X_bib63) (10.1016/S0140-6736(18)32470-X_bib2) 2018 Huh (10.1016/S0140-6736(18)32470-X_bib24) 2017; 390 Ries (10.1016/S0140-6736(18)32470-X_bib5) 2007 Zanagnolo (10.1016/S0140-6736(18)32470-X_bib98) 2009; 19 Piver (10.1016/S0140-6736(18)32470-X_bib48) 1974; 44 Dargent (10.1016/S0140-6736(18)32470-X_bib57) 2000; 88 Melamed (10.1016/S0140-6736(18)32470-X_bib72) 2018; 379 Quinn (10.1016/S0140-6736(18)32470-X_bib44) 2006; 95 Grulich (10.1016/S0140-6736(18)32470-X_bib16) 2007; 370
References_xml	– volume: 22 start-page: 728 year: 2015 end-page: 733 ident: bib29 article-title: Control of cancer of the cervix in low- and middle-income countries publication-title: Ann Surg Oncol – year: 2007 ident: bib5 article-title: SEER cancer statistics review, 1975–2004 – volume: 44 start-page: 265 year: 1974 end-page: 272 ident: bib48 article-title: Five classes of extended hysterectomy for women with cervical cancer publication-title: Obstet Gynecol – year: 2016 ident: bib7 article-title: National Cervical screening program: guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding – volume: 45 start-page: 307 year: 1992 end-page: 312 ident: bib45 article-title: Superficially invasive squamous cell carcinoma of the cervix publication-title: Gynecol Oncol – volume: 178 start-page: 855 year: 2008 end-page: 862 ident: bib41 article-title: Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis publication-title: CMAJ – ident: bib95 article-title: Cervical cancer (version 3.2019) – volume: 38 start-page: 352 year: 1990 end-page: 357 ident: bib73 article-title: Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study publication-title: Gynecol Oncol – volume: 94 start-page: 117 year: 2002 end-page: 124 ident: bib85 article-title: High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix: a randomized trial publication-title: Cancer – volume: 3 year: 2013 ident: bib40 article-title: Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer publication-title: Cochrane Database Syst Rev – volume: 149 start-page: 6 year: 2018 end-page: 7 ident: bib101 article-title: GOG 244, the lymphedema and gynecologic cancer (LEG) study: incidence and risk factors in newly diagnosed patients publication-title: Gynecol Oncol – year: 2018 ident: bib2 article-title: Cervical cancer – volume: 28 start-page: 592 year: 2011 end-page: 598 ident: bib33 article-title: Gynaecological symptoms reported by young women: examining the potential for earlier diagnosis of cervical cancer publication-title: Fam Pract – volume: 59 start-page: 1424 year: 2004 end-page: 1431 ident: bib84 article-title: Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma publication-title: Int J Radiat Oncol Biol Phys – volume: 391 start-page: 1391 year: 2018 end-page: 1454 ident: bib117 article-title: Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the publication-title: Lancet – volume: 102 start-page: 1782 year: 2012 end-page: 1790 ident: bib13 article-title: Association of insurance status and age with cervical cancer stage at diagnosis: national cancer database, 2000–2007 publication-title: Am J Public Health – volume: 4 year: 2015 ident: bib69 article-title: Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer publication-title: Cochrane Database Syst Rev – volume: 24 start-page: 1146 year: 2014 end-page: 1157 ident: bib99 article-title: A systematic review of quality of life and sexual function of patients with cervical cancer after treatment publication-title: Int J Gynecol Cancer – volume: 49 start-page: 3262 year: 2013 end-page: 3273 ident: bib8 article-title: Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors publication-title: Eur J Cancer – volume: 13 start-page: e0185332 year: 2018 ident: bib25 article-title: Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: example from Australia publication-title: PLoS One – volume: 134 start-page: 546 year: 2014 end-page: 551 ident: bib94 article-title: Overall survival after pelvic exenteration for gynecologic malignancy publication-title: Gynecol Oncol – volume: 15 start-page: 10003 year: 2014 end-page: 10008 ident: bib9 article-title: Success of a cervical cancer screening program: trends in incidence in Songkhla, Southern Thailand, 1989–2010, and prediction of future incidences to 2030 publication-title: Asian Pac J Cancer Prev – volume: 64 start-page: e602 year: 2014 end-page: e610 ident: bib34 article-title: Delays in diagnosis of young females with symptomatic cervical cancer in England: an interview-based study publication-title: Br J Gen Pract – volume: 26 start-page: 199 year: 2016 end-page: 207 ident: bib113 article-title: Advances and concepts in Cervical cancer trials: a road map for the future publication-title: Int J Gynecol Cancer – volume: 14 start-page: 207 year: 2014 ident: bib18 article-title: Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia publication-title: BMC Cancer – volume: 17 start-page: e240 year: 2016 end-page: e253 ident: bib58 article-title: Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review publication-title: Lancet Oncol – volume: 146 start-page: 3 year: 2017 end-page: 10 ident: bib97 article-title: An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations publication-title: Gynecol Oncol – volume: 95 start-page: S43 year: 2006 end-page: S103 ident: bib44 article-title: Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer publication-title: Int J Gynaecol Obstet – volume: 135 start-page: 453 year: 2014 end-page: 466 ident: bib19 article-title: Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort publication-title: Int J Cancer – volume: 138 start-page: 457 year: 2015 end-page: 471 ident: bib70 article-title: Robotic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis publication-title: Gynecol Oncol – volume: 36 start-page: 1548 year: 2018 end-page: 1555 ident: bib92 article-title: Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial publication-title: J Clin Oncol – volume: 65 start-page: 87 year: 2015 end-page: 108 ident: bib10 article-title: Global cancer statistics, 2012 publication-title: CA Cancer J Clin – volume: 23 start-page: 1717 year: 2013 end-page: 1725 ident: bib64 article-title: Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study publication-title: Int J Gynecol Cancer – volume: 361 start-page: 2217 year: 2003 end-page: 2225 ident: bib11 article-title: Cervical cancer publication-title: Lancet – volume: 120 start-page: 885 year: 2007 end-page: 891 ident: bib15 article-title: Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies publication-title: Int J Cancer – volume: 87 start-page: 542 year: 2013 end-page: 548 ident: bib112 article-title: Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study publication-title: Int J Radiat Oncol Biol Phys – volume: 36 start-page: 2811 year: 2018 end-page: 2812 ident: bib93 article-title: Treatment protocols for patients with stage IB2, IIA, or IIB squamous cervical cancer publication-title: J Clin Oncol – volume: 350 start-page: 535 year: 1997 end-page: 540 ident: bib50 article-title: Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer publication-title: Lancet – volume: 215 start-page: 460.e1 year: 2016 end-page: 460.e13 ident: bib66 article-title: Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis publication-title: Am J Obstet Gynecol – volume: 7 start-page: 69 year: 2014 ident: bib68 article-title: Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis publication-title: J Ovarian Res – volume: 33 start-page: 2129 year: 2015 end-page: 2135 ident: bib103 article-title: Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III trial JCOG0505 publication-title: J Clin Oncol – volume: 29 start-page: iv262 year: 2018 ident: bib39 article-title: Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up publication-title: Ann Oncol – volume: 18 start-page: 1606 year: 2000 end-page: 1613 ident: bib75 article-title: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix publication-title: J Clin Oncol – ident: bib63 article-title: Stage 1B1 (2-4cm) Cervical cancer treated with neoadjuvant chemotherapy followed by fertility sparing surgery (CONTESSA). Neo-adjuvant chemotherapy and conservative surgery in cervical cancer to preserve fertility (NEOCON-F) – volume: 20 start-page: 900 year: 2010 end-page: 904 ident: bib51 article-title: A prospective study of postoperative lymphedema after surgery for cervical cancer publication-title: Int J Gynecol Cancer – volume: 32 start-page: TPS5632 year: 2014 ident: bib91 article-title: A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: outback (ANZGOG0902/GOG0274/RTOG1174) publication-title: J Clin Oncol – volume: 26 start-page: 1510 year: 2016 end-page: 1514 ident: bib67 article-title: The safety of ovarian preservation in early-stage adenocarcinoma compared with squamous cell carcinoma of uterine cervix: a systematic review and meta-analysis of observational studies publication-title: Int J Gynecol Cancer – volume: 123 start-page: 2404 year: 2017 end-page: 2412 ident: bib4 article-title: Cervical cancer: a global health crisis publication-title: Cancer – volume: 59 start-page: 277 year: 1995 end-page: 282 ident: bib52 article-title: Modified radical hysterectomy: morbidity and mortality publication-title: Gynecol Oncol – volume: 23 start-page: 109 year: 2016 end-page: 118 ident: bib96 article-title: Follow-up for cervical cancer: a Program in Evidence-Based Care systematic review and clinical practice guideline update publication-title: Curr Oncol – volume: 103 start-page: 807 year: 2006 end-page: 813 ident: bib56 article-title: Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: technique and review of the literature publication-title: Gynecol Oncol – ident: bib21 article-title: The gap report – volume: 68 start-page: 394 year: 2018 end-page: 424 ident: bib1 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – volume: 15 start-page: 565 year: 2015 end-page: 580 ident: bib27 article-title: Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis publication-title: Lancet Infect Dis – volume: 43 start-page: 763 year: 1999 end-page: 775 ident: bib83 article-title: Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy publication-title: Int J Radiat Oncol Biol Phys – volume: 383 start-page: 524 year: 2014 end-page: 532 ident: bib30 article-title: Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials publication-title: Lancet – ident: bib106 article-title: FDA approves pembrolizumab for advanced cervical cancer with disease progression during or after chemotherapy – volume: 379 start-page: 1895 year: 2018 end-page: 1904 ident: bib71 article-title: Minimally invasive versus abdominal radical hysterectomy for cervical cancer publication-title: N Engl J Med – volume: 472 start-page: 919 year: 2018 end-page: 936 ident: bib6 article-title: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer publication-title: Virchows Arch – volume: 382 start-page: 889 year: 2013 end-page: 899 ident: bib20 article-title: Human papillomavirus and cervical cancer publication-title: Lancet – volume: 88 start-page: 1877 year: 2000 end-page: 1882 ident: bib57 article-title: Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients publication-title: Cancer – volume: 379 start-page: 1905 year: 2018 end-page: 1914 ident: bib72 article-title: Survival after minimally invasive radical hysterectomy for early-stage cervical cancer publication-title: N Engl J Med – volume: 24 start-page: 531 year: 2007 end-page: 539 ident: bib62 article-title: Management of pregnancy after radical trachelectomy: case reports and systematic review of the literature publication-title: Am J Perinatol – volume: 543 start-page: 378 year: 2017 end-page: 384 ident: bib115 article-title: Integrated genomic and molecular characterization of cervical cancer publication-title: Nature – volume: 87 start-page: 111 year: 2013 end-page: 119 ident: bib86 article-title: Trends in the utilization of brachytherapy in cervical cancer in the United States publication-title: Int J Radiat Oncol Biol Phys – volume: 9 start-page: 297 year: 2008 end-page: 303 ident: bib49 article-title: Classification of radical hysterectomy publication-title: Lancet Oncol – volume: 1 year: 2010 ident: bib81 article-title: Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis publication-title: Cochrane Database Syst Rev – volume: 104 start-page: 428 year: 2007 end-page: 434 ident: bib65 article-title: Sexual health in women treated for cervical cancer: characteristics and correlates publication-title: Gynecol Oncol – volume: 382 start-page: 889 year: 2013 end-page: 899 ident: bib14 article-title: Human papillomavirus and cervical cancer publication-title: Lancet – volume: 4 start-page: 353 year: 2007 end-page: 361 ident: bib59 article-title: Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer publication-title: Nat Clin Pract Oncol – volume: 63 start-page: 4 year: 1996 end-page: 9 ident: bib47 article-title: Lymph node metastases and prognosis in patients with stage IA2 cervical cancer publication-title: Gynecol Oncol – volume: 340 start-page: 1144 year: 1999 end-page: 1153 ident: bib80 article-title: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer publication-title: N Engl J Med – volume: 190 start-page: 37 year: 2018 end-page: 45 ident: bib22 article-title: Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type publication-title: J Infect Dis – volume: 29 start-page: 1678 year: 2011 end-page: 1685 ident: bib90 article-title: Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix publication-title: J Clin Oncol – volume: 23 start-page: 982 year: 2013 end-page: 989 ident: bib55 article-title: Evolution in fertility-preserving options for early-stage cervical cancer: radical trachelectomy, simple trachelectomy, neoadjuvant chemotherapy publication-title: Int J Gynecol Cancer – volume: 9 start-page: 48 year: 2018 end-page: 60 ident: bib89 article-title: The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies publication-title: Clin Transl Radiat Oncol – volume: 36 start-page: 5522 year: 2018 ident: bib107 article-title: Pembrolizumab treatment of advanced cervical cancer: updated results from the phase 2 KEYNOTE-158 study publication-title: J Clin Oncol – volume: 19 start-page: e113 year: 2018 end-page: e122 ident: bib32 article-title: Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India publication-title: Lancet Oncol – volume: 377 start-page: 2085 year: 2011 end-page: 2092 ident: bib26 article-title: Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study publication-title: Lancet – year: 2018 ident: bib46 article-title: NCCN clinical practice guidelines in oncology, cervical cancer, version 2.2019—Oct 12 – volume: 28 start-page: 419 year: 2016 end-page: 428 ident: bib87 article-title: Image-guided adaptive brachytherapy in locally advanced cervical cancer: recent advances and perspectives publication-title: Curr Opin Oncol – volume: 21 start-page: 101 year: 2017 end-page: 108 ident: bib23 article-title: Cervical cancer control in HIV-infected women: past, present and future publication-title: Gynecol Oncol Rep – volume: 107 start-page: 947 year: 2012 end-page: 955 ident: bib116 article-title: BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib publication-title: Brit J Cancer – volume: 382 start-page: 889 year: 2013 end-page: 899 ident: bib3 article-title: Human papillomavirus and cervical cancer publication-title: Lancet – volume: 99 start-page: S152 year: 2005 end-page: S156 ident: bib61 article-title: Pregnancy after radical trachelectomy: a real option? publication-title: Gynecol Oncol – volume: 8 start-page: 1007 year: 2007 end-page: 1017 ident: bib100 article-title: Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients publication-title: Lancet Oncol – volume: 36 start-page: 3381 year: 2018 end-page: 3386 ident: bib28 article-title: Human papillomavirus vaccination in commercially-insured vaccine-eligible males and females, United States, 2007–2014 publication-title: Vaccine – volume: 320 start-page: 43 year: 2018 end-page: 52 ident: bib31 article-title: Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial publication-title: JAMA – volume: 33 start-page: 1543 year: 2015 end-page: 1550 ident: bib110 article-title: Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells publication-title: J Clin Oncol – volume: 32 start-page: 135 year: 1989 end-page: 142 ident: bib76 article-title: Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: a clinical review of 954 cases publication-title: Gynecol Oncol – year: 2012 ident: bib35 article-title: Cervical cancer: contemporary management – volume: 103 start-page: 305 year: 2012 end-page: 313 ident: bib88 article-title: Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study publication-title: Radiother Oncol – volume: 19 start-page: 306 year: 2009 end-page: 313 ident: bib98 article-title: Surveillance procedures for patients for cervical carcinoma: a review of the literature publication-title: Int J Gynecol Cancer – volume: 143 start-page: 2238 year: 2018 end-page: 2249 ident: bib12 article-title: Temporal trends in the epidemiology of cervical cancer in South Africa (1994–2012) publication-title: Int J Cancer – volume: 340 start-page: 1154 year: 1999 end-page: 1161 ident: bib79 article-title: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma publication-title: N Engl J Med – volume: 12 start-page: 279 year: 2014 ident: bib102 article-title: Surgical results of pelvic exenteration in the treatment of gynecologic cancer publication-title: World J Surg Oncol – volume: 3 start-page: 93 year: 2017 end-page: 97 ident: bib105 article-title: Bevacizumab in advanced cervical cancer: issues and challenges for low- and middle-income countries publication-title: J Glob Oncol – volume: 70 start-page: 209 year: 2000 end-page: 262 ident: bib36 article-title: FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology publication-title: Int J Gynaecol Obstet – volume: 390 start-page: 1654 year: 2017 end-page: 1663 ident: bib104 article-title: Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240) publication-title: Lancet – volume: 121 start-page: 290 year: 2011 end-page: 297 ident: bib60 article-title: The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies publication-title: Gynecol Oncol – volume: 73 start-page: 177 year: 1999 end-page: 183 ident: bib74 article-title: A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study publication-title: Gynecol Oncol – volume: 23 start-page: 9329 year: 2005 end-page: 9337 ident: bib43 article-title: Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183 publication-title: J Clin Oncol – volume: 36 start-page: 2538 year: 2018 end-page: 2544 ident: bib114 article-title: Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology-RTOG 1203 publication-title: J Clin Oncol – volume: 108 start-page: 176 year: 2010 ident: bib37 article-title: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium publication-title: Int J Gynecol Obstet – volume: 92 start-page: 525 year: 2004 end-page: 529 ident: bib77 article-title: Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? publication-title: Gynecol Oncol – volume: 80 start-page: 1436 year: 2011 end-page: 1445 ident: bib111 article-title: Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix publication-title: Int J Radiat Oncol Biol Phys – volume: 17 start-page: 1471 year: 2010 end-page: 1474 ident: bib38 article-title: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM publication-title: Ann Surg Oncol – volume: 6 start-page: S5 year: 2018 end-page: S6 ident: bib118 article-title: The publication-title: Lancet Glob Health – volume: 119 start-page: 2372 year: 2006 end-page: 2375 ident: bib17 article-title: Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands publication-title: Int J Cancer – volume: 120 start-page: 321 year: 2011 end-page: 325 ident: bib53 article-title: Conservative management of early stage cervical cancer: is there a role for less radical surgery? publication-title: Gynecol Oncol – volume: 33 start-page: 2199 year: 2013 end-page: 2204 ident: bib78 article-title: Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival publication-title: Anticancer Res – volume: 4 start-page: 506 year: 2018 end-page: 513 ident: bib82 article-title: Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: a randomized clinical trial publication-title: JAMA Oncol – volume: 370 start-page: 59 year: 2007 end-page: 67 ident: bib16 article-title: Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis publication-title: Lancet – volume: 27 start-page: 3975 year: 2009 end-page: 3983 ident: bib109 article-title: The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix publication-title: Vaccine – volume: 390 start-page: 2143 year: 2017 end-page: 2159 ident: bib24 article-title: Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial publication-title: Lancet – volume: 97 start-page: 183 year: 2005 end-page: 191 ident: bib42 article-title: FDG-PET for management of cervical and ovarian cancer publication-title: Gynecol Oncol – volume: 137 start-page: 574 year: 2015 end-page: 580 ident: bib54 article-title: Immediate radical trachelectomy versus neoadjuvant chemotherapy followed by conservative surgery for patients with stage IB1 cervical cancer with tumors 2 cm or larger: a literature review and analysis of oncological and obstetrical outcomes publication-title: Gynecol Oncol – volume: 35 start-page: 5504 year: 2017 ident: bib108 article-title: An open-label, multicohort, phase I/II study of nivolumab in patients with virus-associated tumors (CheckMate 358): efficacy and safety in recurrent or metastatic (R/M) cervical, vaginal, and vulvar cancers publication-title: J Clin Oncol – volume: 379 start-page: 1905 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib72 article-title: Survival after minimally invasive radical hysterectomy for early-stage cervical cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1804923 – volume: 73 start-page: 177 year: 1999 ident: 10.1016/S0140-6736(18)32470-X_bib74 article-title: A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study publication-title: Gynecol Oncol doi: 10.1006/gyno.1999.5387 – volume: 68 start-page: 394 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib1 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – volume: 121 start-page: 290 year: 2011 ident: 10.1016/S0140-6736(18)32470-X_bib60 article-title: The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2010.12.345 – volume: 29 start-page: iv262 issue: suppl 4 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib39 article-title: Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up publication-title: Ann Oncol doi: 10.1093/annonc/mdy160 – volume: 17 start-page: e240 year: 2016 ident: 10.1016/S0140-6736(18)32470-X_bib58 article-title: Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review publication-title: Lancet Oncol doi: 10.1016/S1470-2045(16)30032-8 – volume: 19 start-page: 306 year: 2009 ident: 10.1016/S0140-6736(18)32470-X_bib98 article-title: Surveillance procedures for patients for cervical carcinoma: a review of the literature publication-title: Int J Gynecol Cancer doi: 10.1111/IGC.0b013e3181a130f3 – volume: 64 start-page: e602 year: 2014 ident: 10.1016/S0140-6736(18)32470-X_bib34 article-title: Delays in diagnosis of young females with symptomatic cervical cancer in England: an interview-based study publication-title: Br J Gen Pract doi: 10.3399/bjgp14X681757 – volume: 4 start-page: 353 year: 2007 ident: 10.1016/S0140-6736(18)32470-X_bib59 article-title: Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer publication-title: Nat Clin Pract Oncol doi: 10.1038/ncponc0822 – volume: 391 start-page: 1391 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib117 article-title: Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the Lancet Commission report publication-title: Lancet doi: 10.1016/S0140-6736(17)32513-8 – volume: 14 start-page: 207 year: 2014 ident: 10.1016/S0140-6736(18)32470-X_bib18 article-title: Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia publication-title: BMC Cancer doi: 10.1186/1471-2407-14-207 – volume: 13 start-page: e0185332 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib25 article-title: Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: example from Australia publication-title: PLoS One doi: 10.1371/journal.pone.0185332 – volume: 33 start-page: 2129 year: 2015 ident: 10.1016/S0140-6736(18)32470-X_bib103 article-title: Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III trial JCOG0505 publication-title: J Clin Oncol doi: 10.1200/JCO.2014.58.4391 – volume: 28 start-page: 419 year: 2016 ident: 10.1016/S0140-6736(18)32470-X_bib87 article-title: Image-guided adaptive brachytherapy in locally advanced cervical cancer: recent advances and perspectives publication-title: Curr Opin Oncol doi: 10.1097/CCO.0000000000000309 – volume: 95 start-page: S43 issue: suppl 1 year: 2006 ident: 10.1016/S0140-6736(18)32470-X_bib44 article-title: Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer publication-title: Int J Gynaecol Obstet – volume: 107 start-page: 947 year: 2012 ident: 10.1016/S0140-6736(18)32470-X_bib116 article-title: BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib publication-title: Brit J Cancer doi: 10.1038/bjc.2012.351 – volume: 3 year: 2013 ident: 10.1016/S0140-6736(18)32470-X_bib40 article-title: Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer publication-title: Cochrane Database Syst Rev – volume: 35 start-page: 5504 issue: suppl 15 year: 2017 ident: 10.1016/S0140-6736(18)32470-X_bib108 article-title: An open-label, multicohort, phase I/II study of nivolumab in patients with virus-associated tumors (CheckMate 358): efficacy and safety in recurrent or metastatic (R/M) cervical, vaginal, and vulvar cancers publication-title: J Clin Oncol doi: 10.1200/JCO.2017.35.15_suppl.5504 – volume: 4 year: 2015 ident: 10.1016/S0140-6736(18)32470-X_bib69 article-title: Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer publication-title: Cochrane Database Syst Rev – volume: 4 start-page: 506 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib82 article-title: Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: a randomized clinical trial publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2017.5179 – volume: 97 start-page: 183 year: 2005 ident: 10.1016/S0140-6736(18)32470-X_bib42 article-title: FDG-PET for management of cervical and ovarian cancer publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2004.12.007 – volume: 23 start-page: 1717 year: 2013 ident: 10.1016/S0140-6736(18)32470-X_bib64 article-title: Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0b013e3182a80a65 – volume: 6 start-page: S5 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib118 article-title: The Lancet Commission on Palliative Care and Pain Relief—findings, recommendations, and future directions publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(18)30082-2 – volume: 33 start-page: 1543 year: 2015 ident: 10.1016/S0140-6736(18)32470-X_bib110 article-title: Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells publication-title: J Clin Oncol doi: 10.1200/JCO.2014.58.9093 – volume: 390 start-page: 1654 year: 2017 ident: 10.1016/S0140-6736(18)32470-X_bib104 article-title: Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240) publication-title: Lancet doi: 10.1016/S0140-6736(17)31607-0 – volume: 123 start-page: 2404 year: 2017 ident: 10.1016/S0140-6736(18)32470-X_bib4 article-title: Cervical cancer: a global health crisis publication-title: Cancer doi: 10.1002/cncr.30667 – volume: 119 start-page: 2372 year: 2006 ident: 10.1016/S0140-6736(18)32470-X_bib17 article-title: Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands publication-title: Int J Cancer doi: 10.1002/ijc.22114 – volume: 120 start-page: 321 year: 2011 ident: 10.1016/S0140-6736(18)32470-X_bib53 article-title: Conservative management of early stage cervical cancer: is there a role for less radical surgery? publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2010.12.352 – volume: 382 start-page: 889 year: 2013 ident: 10.1016/S0140-6736(18)32470-X_bib20 article-title: Human papillomavirus and cervical cancer publication-title: Lancet doi: 10.1016/S0140-6736(13)60022-7 – volume: 24 start-page: 1146 year: 2014 ident: 10.1016/S0140-6736(18)32470-X_bib99 article-title: A systematic review of quality of life and sexual function of patients with cervical cancer after treatment publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0000000000000207 – volume: 472 start-page: 919 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib6 article-title: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer publication-title: Virchows Arch doi: 10.1007/s00428-018-2362-9 – volume: 87 start-page: 111 year: 2013 ident: 10.1016/S0140-6736(18)32470-X_bib86 article-title: Trends in the utilization of brachytherapy in cervical cancer in the United States publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2013.05.033 – volume: 26 start-page: 1510 year: 2016 ident: 10.1016/S0140-6736(18)32470-X_bib67 article-title: The safety of ovarian preservation in early-stage adenocarcinoma compared with squamous cell carcinoma of uterine cervix: a systematic review and meta-analysis of observational studies publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0000000000000780 – volume: 377 start-page: 2085 year: 2011 ident: 10.1016/S0140-6736(18)32470-X_bib26 article-title: Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study publication-title: Lancet doi: 10.1016/S0140-6736(11)60551-5 – volume: 143 start-page: 2238 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib12 article-title: Temporal trends in the epidemiology of cervical cancer in South Africa (1994–2012) publication-title: Int J Cancer doi: 10.1002/ijc.31610 – volume: 94 start-page: 117 year: 2002 ident: 10.1016/S0140-6736(18)32470-X_bib85 article-title: High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix: a randomized trial publication-title: Cancer doi: 10.1002/cncr.10207 – volume: 17 start-page: 1471 year: 2010 ident: 10.1016/S0140-6736(18)32470-X_bib38 article-title: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM publication-title: Ann Surg Oncol doi: 10.1245/s10434-010-0985-4 – volume: 18 start-page: 1606 year: 2000 ident: 10.1016/S0140-6736(18)32470-X_bib75 article-title: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix publication-title: J Clin Oncol doi: 10.1200/JCO.2000.18.8.1606 – ident: 10.1016/S0140-6736(18)32470-X_bib63 – volume: 27 start-page: 3975 year: 2009 ident: 10.1016/S0140-6736(18)32470-X_bib109 article-title: The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix publication-title: Vaccine doi: 10.1016/j.vaccine.2009.04.041 – volume: 382 start-page: 889 year: 2013 ident: 10.1016/S0140-6736(18)32470-X_bib3 article-title: Human papillomavirus and cervical cancer publication-title: Lancet doi: 10.1016/S0140-6736(13)60022-7 – volume: 49 start-page: 3262 year: 2013 ident: 10.1016/S0140-6736(18)32470-X_bib8 article-title: Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors publication-title: Eur J Cancer doi: 10.1016/j.ejca.2013.04.024 – volume: 15 start-page: 10003 year: 2014 ident: 10.1016/S0140-6736(18)32470-X_bib9 article-title: Success of a cervical cancer screening program: trends in incidence in Songkhla, Southern Thailand, 1989–2010, and prediction of future incidences to 2030 publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2014.15.22.10003 – volume: 9 start-page: 297 year: 2008 ident: 10.1016/S0140-6736(18)32470-X_bib49 article-title: Classification of radical hysterectomy publication-title: Lancet Oncol doi: 10.1016/S1470-2045(08)70074-3 – volume: 36 start-page: 1548 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib92 article-title: Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial publication-title: J Clin Oncol doi: 10.1200/JCO.2017.75.9985 – volume: 178 start-page: 855 year: 2008 ident: 10.1016/S0140-6736(18)32470-X_bib41 article-title: Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis publication-title: CMAJ doi: 10.1503/cmaj.071124 – year: 2007 ident: 10.1016/S0140-6736(18)32470-X_bib5 – volume: 22 start-page: 728 year: 2015 ident: 10.1016/S0140-6736(18)32470-X_bib29 article-title: Control of cancer of the cervix in low- and middle-income countries publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-4344-8 – volume: 15 start-page: 565 year: 2015 ident: 10.1016/S0140-6736(18)32470-X_bib27 article-title: Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(14)71073-4 – volume: 36 start-page: 5522 issue: suppl 15 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib107 article-title: Pembrolizumab treatment of advanced cervical cancer: updated results from the phase 2 KEYNOTE-158 study publication-title: J Clin Oncol doi: 10.1200/JCO.2018.36.15_suppl.5522 – volume: 24 start-page: 531 year: 2007 ident: 10.1016/S0140-6736(18)32470-X_bib62 article-title: Management of pregnancy after radical trachelectomy: case reports and systematic review of the literature publication-title: Am J Perinatol doi: 10.1055/s-2007-986680 – volume: 190 start-page: 37 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib22 article-title: Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type publication-title: J Infect Dis doi: 10.1086/421467 – volume: 33 start-page: 2199 year: 2013 ident: 10.1016/S0140-6736(18)32470-X_bib78 article-title: Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival publication-title: Anticancer Res – volume: 3 start-page: 93 year: 2017 ident: 10.1016/S0140-6736(18)32470-X_bib105 article-title: Bevacizumab in advanced cervical cancer: issues and challenges for low- and middle-income countries publication-title: J Glob Oncol doi: 10.1200/JGO.2016.004895 – volume: 36 start-page: 2538 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib114 article-title: Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology-RTOG 1203 publication-title: J Clin Oncol doi: 10.1200/JCO.2017.77.4273 – volume: 12 start-page: 279 year: 2014 ident: 10.1016/S0140-6736(18)32470-X_bib102 article-title: Surgical results of pelvic exenteration in the treatment of gynecologic cancer publication-title: World J Surg Oncol doi: 10.1186/1477-7819-12-279 – year: 2012 ident: 10.1016/S0140-6736(18)32470-X_bib35 – volume: 104 start-page: 428 year: 2007 ident: 10.1016/S0140-6736(18)32470-X_bib65 article-title: Sexual health in women treated for cervical cancer: characteristics and correlates publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2006.08.009 – volume: 21 start-page: 101 year: 2017 ident: 10.1016/S0140-6736(18)32470-X_bib23 article-title: Cervical cancer control in HIV-infected women: past, present and future publication-title: Gynecol Oncol Rep doi: 10.1016/j.gore.2017.07.009 – volume: 26 start-page: 199 year: 2016 ident: 10.1016/S0140-6736(18)32470-X_bib113 article-title: Advances and concepts in Cervical cancer trials: a road map for the future publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0000000000000587 – volume: 65 start-page: 87 year: 2015 ident: 10.1016/S0140-6736(18)32470-X_bib10 article-title: Global cancer statistics, 2012 publication-title: CA Cancer J Clin – volume: 370 start-page: 59 year: 2007 ident: 10.1016/S0140-6736(18)32470-X_bib16 article-title: Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis publication-title: Lancet doi: 10.1016/S0140-6736(07)61050-2 – volume: 383 start-page: 524 year: 2014 ident: 10.1016/S0140-6736(18)32470-X_bib30 article-title: Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials publication-title: Lancet doi: 10.1016/S0140-6736(13)62218-7 – volume: 543 start-page: 378 year: 2017 ident: 10.1016/S0140-6736(18)32470-X_bib115 article-title: Integrated genomic and molecular characterization of cervical cancer publication-title: Nature doi: 10.1038/nature21386 – volume: 215 start-page: 460.e1 year: 2016 ident: 10.1016/S0140-6736(18)32470-X_bib66 article-title: Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2016.04.023 – volume: 23 start-page: 109 year: 2016 ident: 10.1016/S0140-6736(18)32470-X_bib96 article-title: Follow-up for cervical cancer: a Program in Evidence-Based Care systematic review and clinical practice guideline update publication-title: Curr Oncol doi: 10.3747/co.23.2742 – volume: 379 start-page: 1895 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib71 article-title: Minimally invasive versus abdominal radical hysterectomy for cervical cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1806395 – volume: 103 start-page: 305 year: 2012 ident: 10.1016/S0140-6736(18)32470-X_bib88 article-title: Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study publication-title: Radiother Oncol doi: 10.1016/j.radonc.2012.04.007 – volume: 361 start-page: 2217 year: 2003 ident: 10.1016/S0140-6736(18)32470-X_bib11 article-title: Cervical cancer publication-title: Lancet doi: 10.1016/S0140-6736(03)13778-6 – volume: 135 start-page: 453 year: 2014 ident: 10.1016/S0140-6736(18)32470-X_bib19 article-title: Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort publication-title: Int J Cancer doi: 10.1002/ijc.28666 – volume: 99 start-page: S152 issue: 3 suppl 1 year: 2005 ident: 10.1016/S0140-6736(18)32470-X_bib61 article-title: Pregnancy after radical trachelectomy: a real option? publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2005.07.071 – volume: 7 start-page: 69 year: 2014 ident: 10.1016/S0140-6736(18)32470-X_bib68 article-title: Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis publication-title: J Ovarian Res doi: 10.1186/1757-2215-7-69 – volume: 36 start-page: 3381 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib28 article-title: Human papillomavirus vaccination in commercially-insured vaccine-eligible males and females, United States, 2007–2014 publication-title: Vaccine doi: 10.1016/j.vaccine.2018.03.045 – volume: 137 start-page: 574 year: 2015 ident: 10.1016/S0140-6736(18)32470-X_bib54 article-title: Immediate radical trachelectomy versus neoadjuvant chemotherapy followed by conservative surgery for patients with stage IB1 cervical cancer with tumors 2 cm or larger: a literature review and analysis of oncological and obstetrical outcomes publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2015.03.051 – volume: 80 start-page: 1436 year: 2011 ident: 10.1016/S0140-6736(18)32470-X_bib111 article-title: Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2010.04.041 – volume: 103 start-page: 807 year: 2006 ident: 10.1016/S0140-6736(18)32470-X_bib56 article-title: Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: technique and review of the literature publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2006.05.044 – volume: 45 start-page: 307 year: 1992 ident: 10.1016/S0140-6736(18)32470-X_bib45 article-title: Superficially invasive squamous cell carcinoma of the cervix publication-title: Gynecol Oncol doi: 10.1016/0090-8258(92)90310-F – volume: 44 start-page: 265 year: 1974 ident: 10.1016/S0140-6736(18)32470-X_bib48 article-title: Five classes of extended hysterectomy for women with cervical cancer publication-title: Obstet Gynecol – volume: 23 start-page: 982 year: 2013 ident: 10.1016/S0140-6736(18)32470-X_bib55 article-title: Evolution in fertility-preserving options for early-stage cervical cancer: radical trachelectomy, simple trachelectomy, neoadjuvant chemotherapy publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0b013e318295906b – volume: 134 start-page: 546 year: 2014 ident: 10.1016/S0140-6736(18)32470-X_bib94 article-title: Overall survival after pelvic exenteration for gynecologic malignancy publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2014.06.034 – volume: 63 start-page: 4 year: 1996 ident: 10.1016/S0140-6736(18)32470-X_bib47 article-title: Lymph node metastases and prognosis in patients with stage IA2 cervical cancer publication-title: Gynecol Oncol doi: 10.1006/gyno.1996.0268 – volume: 108 start-page: 176 year: 2010 ident: 10.1016/S0140-6736(18)32470-X_bib37 article-title: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium publication-title: Int J Gynecol Obstet doi: 10.1016/j.ijgo.2009.08.009 – volume: 28 start-page: 592 year: 2011 ident: 10.1016/S0140-6736(18)32470-X_bib33 article-title: Gynaecological symptoms reported by young women: examining the potential for earlier diagnosis of cervical cancer publication-title: Fam Pract doi: 10.1093/fampra/cmr033 – volume: 32 start-page: 135 year: 1989 ident: 10.1016/S0140-6736(18)32470-X_bib76 article-title: Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: a clinical review of 954 cases publication-title: Gynecol Oncol doi: 10.1016/S0090-8258(89)80024-1 – volume: 23 start-page: 9329 year: 2005 ident: 10.1016/S0140-6736(18)32470-X_bib43 article-title: Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.02.0354 – volume: 20 start-page: 900 year: 2010 ident: 10.1016/S0140-6736(18)32470-X_bib51 article-title: A prospective study of postoperative lymphedema after surgery for cervical cancer publication-title: Int J Gynecol Cancer doi: 10.1111/IGC.0b013e3181da29d0 – volume: 43 start-page: 763 year: 1999 ident: 10.1016/S0140-6736(18)32470-X_bib83 article-title: Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/S0360-3016(98)00482-9 – volume: 1 year: 2010 ident: 10.1016/S0140-6736(18)32470-X_bib81 article-title: Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis publication-title: Cochrane Database Syst Rev – volume: 36 start-page: 2811 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib93 article-title: Treatment protocols for patients with stage IB2, IIA, or IIB squamous cervical cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2018.78.8893 – volume: 87 start-page: 542 year: 2013 ident: 10.1016/S0140-6736(18)32470-X_bib112 article-title: Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2013.06.2059 – year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib2 – volume: 70 start-page: 209 year: 2000 ident: 10.1016/S0140-6736(18)32470-X_bib36 article-title: FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology publication-title: Int J Gynaecol Obstet doi: 10.1016/S0020-7292(00)90001-8 – volume: 138 start-page: 457 year: 2015 ident: 10.1016/S0140-6736(18)32470-X_bib70 article-title: Robotic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2015.06.009 – volume: 320 start-page: 43 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib31 article-title: Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2018.7464 – volume: 19 start-page: e113 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib32 article-title: Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India publication-title: Lancet Oncol doi: 10.1016/S1470-2045(18)30003-2 – volume: 340 start-page: 1144 year: 1999 ident: 10.1016/S0140-6736(18)32470-X_bib80 article-title: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer publication-title: N Engl J Med doi: 10.1056/NEJM199904153401502 – volume: 149 start-page: 6 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib101 article-title: GOG 244, the lymphedema and gynecologic cancer (LEG) study: incidence and risk factors in newly diagnosed patients publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2018.04.022 – volume: 59 start-page: 277 year: 1995 ident: 10.1016/S0140-6736(18)32470-X_bib52 article-title: Modified radical hysterectomy: morbidity and mortality publication-title: Gynecol Oncol doi: 10.1006/gyno.1995.0022 – year: 2016 ident: 10.1016/S0140-6736(18)32470-X_bib7 – volume: 59 start-page: 1424 year: 2004 ident: 10.1016/S0140-6736(18)32470-X_bib84 article-title: Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2004.01.034 – volume: 29 start-page: 1678 year: 2011 ident: 10.1016/S0140-6736(18)32470-X_bib90 article-title: Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix publication-title: J Clin Oncol doi: 10.1200/JCO.2009.25.9663 – volume: 9 start-page: 48 year: 2018 ident: 10.1016/S0140-6736(18)32470-X_bib89 article-title: The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies publication-title: Clin Transl Radiat Oncol – volume: 102 start-page: 1782 year: 2012 ident: 10.1016/S0140-6736(18)32470-X_bib13 article-title: Association of insurance status and age with cervical cancer stage at diagnosis: national cancer database, 2000–2007 publication-title: Am J Public Health doi: 10.2105/AJPH.2011.300532 – volume: 88 start-page: 1877 year: 2000 ident: 10.1016/S0140-6736(18)32470-X_bib57 article-title: Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients publication-title: Cancer doi: 10.1002/(SICI)1097-0142(20000415)88:8<1877::AID-CNCR17>3.0.CO;2-W – volume: 8 start-page: 1007 year: 2007 ident: 10.1016/S0140-6736(18)32470-X_bib100 article-title: Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients publication-title: Lancet Oncol doi: 10.1016/S1470-2045(07)70341-8 – volume: 92 start-page: 525 year: 2004 ident: 10.1016/S0140-6736(18)32470-X_bib77 article-title: Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2003.11.020 – volume: 390 start-page: 2143 year: 2017 ident: 10.1016/S0140-6736(18)32470-X_bib24 article-title: Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial publication-title: Lancet doi: 10.1016/S0140-6736(17)31821-4 – volume: 350 start-page: 535 year: 1997 ident: 10.1016/S0140-6736(18)32470-X_bib50 article-title: Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer publication-title: Lancet doi: 10.1016/S0140-6736(97)02250-2 – volume: 38 start-page: 352 year: 1990 ident: 10.1016/S0140-6736(18)32470-X_bib73 article-title: Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study publication-title: Gynecol Oncol doi: 10.1016/0090-8258(90)90072-S – volume: 32 start-page: TPS5632 issue: suppl 15 year: 2014 ident: 10.1016/S0140-6736(18)32470-X_bib91 article-title: A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: outback (ANZGOG0902/GOG0274/RTOG1174) publication-title: J Clin Oncol doi: 10.1200/jco.2014.32.15_suppl.tps5632 – volume: 340 start-page: 1154 year: 1999 ident: 10.1016/S0140-6736(18)32470-X_bib79 article-title: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma publication-title: N Engl J Med doi: 10.1056/NEJM199904153401503 – volume: 382 start-page: 889 year: 2013 ident: 10.1016/S0140-6736(18)32470-X_bib14 article-title: Human papillomavirus and cervical cancer publication-title: Lancet doi: 10.1016/S0140-6736(13)60022-7 – volume: 120 start-page: 885 year: 2007 ident: 10.1016/S0140-6736(18)32470-X_bib15 article-title: Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies publication-title: Int J Cancer doi: 10.1002/ijc.22357 – volume: 146 start-page: 3 year: 2017 ident: 10.1016/S0140-6736(18)32470-X_bib97 article-title: An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2017.03.022
SSID	ssj0004605
Score	2.7270098
SecondaryResourceType	review_article
Snippet	Each year, more than half a million women are diagnosed with cervical cancer and the disease results in over 300 000 deaths worldwide. High-risk subtypes of... Summary Each year, more than half a million women are diagnosed with cervical cancer and the disease results in over 300 000 deaths worldwide. High-risk...
SourceID	proquest pubmed crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	169
SubjectTerms	Bevacizumab Cancer Cervical cancer Cervix Chemoradiotherapy Female Fertility Global Health Health risk assessment Healthcare Disparities - statistics & numerical data HIV Human immunodeficiency virus Human papillomavirus Humans Hysterectomy Immunotherapy Incidence Income Mass Screening - methods Mass Screening - statistics & numerical data Metastases Monoclonal antibodies Mortality Neoplasm Staging Papillomavirus Infections - epidemiology Papillomavirus Vaccines - immunology Poverty Radiation therapy Risk Factors Screening Solid tumors Targeted cancer therapy Toxicity Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - therapy Vaccination Vaccines Vascular endothelial growth factor Viruses Womens health
Title	Cervical cancer
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S014067361832470X https://dx.doi.org/10.1016/S0140-6736(18)32470-X https://www.ncbi.nlm.nih.gov/pubmed/30638582 https://www.proquest.com/docview/2166090092 https://www.proquest.com/docview/2179324728
Volume	393
WOSCitedRecordID	wos000455437100030&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1474-547X dateEnd: 20250907 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M7P dateStart: 19920104 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Consumer Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250907 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0R dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/familyhealth providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1474-547X dateEnd: 20250907 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7X7 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database customDbUrl: eissn: 1474-547X dateEnd: 20250907 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0T dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & allied health premium. customDbUrl: eissn: 1474-547X dateEnd: 20250907 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7RV dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1474-547X dateEnd: 20250907 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: BENPR dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: PsycINFO customDbUrl: eissn: 1474-547X dateEnd: 20250907 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2M dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250907 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 8C1 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1474-547X dateEnd: 20250907 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2O dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 1474-547X dateEnd: 20250907 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2P dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDLZ4CXHh_RgvgcQBDmFN1zbZCcEE4rIx8VJvVeskEhLaYBv8fpw0LRdeEhdLbeOqTRz7c-LYAEeq4KGJlWJI1p-RhcpZwWXAihYS2kdySQy6YhOi15Np2u77BbexD6usdKJT1GqIdo28GfIkCdo2RdDZyyuzVaPs7qovoTENs9zabpJncfv41blIF-L-eYKneVffPObyhFCFCFj6nW36Dns6G3S19N-vX4ZFjz4PzktxWYEpPViF-a7fX1-DxY5THdQErTSM1uHh6vK-c818yQSGUSQmzCAvAqHJNcRAaSS_N8HQ5OQGKWzbVHBKJEqFQucEC5WiGYtaGB4XQWQzuWNrA2YGw4HeggMj0MQSeawItXBs56KVGwIDcRFro5KoAVHVWRn6fOK2rMVz9kXgGJeZ6-MsbcBpzfZSJtT4jSGpRiKrTouSfstI5f_GKGtGDydKmPAX1t1qGDM_p8fZ5xg24LB-TLPRbrHkAz18s21I39E7QtmAzVJU6r9sWXQYy3D755fvwAKBMhvExni4CzOT0Zvegzl8nzyNR_tOwC1NhaOSqOzwfZi9uOz1b-mqG5T03tKw6-iNo31LRf8DOxcDgg
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3fb9MwED6VbWK8FBhsFAp0EkjjwSx2kzh9QGjqVnXaWiHRSXkzydmWJk3t1nag_VP7GznnV1_WlZc-8Jr4rCR3_u67-HwH8EmnXNhAa4bk_Rl5qISlPPJY2kZi-0ghicWs2YQcDqM47vyowX15FsalVZaYmAG1nqD7R34oeBh6HVci6Pv1DXNdo9zuatlCIzeLM3P3h0K22bfTY9LvZyF6J6NunxVdBRj6vpwzizz1pKHoCT1tkELDEIVNKFLQ2HHV0rQMtRbSJMSctCajRiMtD1LPd8XOsU3zPoFNwnHpUshkLB86h5ml1C9ODB3-rC4e8OgLsRjpsXiZL1zGdTOf13v-v32tF1Av2HXrKF8OL6FmxjvwdFDkD7yCejeDRhqCztqnr-FiLY-zCxvjydi8gZaVaIMIeaCJlXHsJLKdWCI7QRoYq0O_AX6pHIVFvXTXtuNKPZAYxyOV6VTFDfhaiV3nBUNWCYSl5lV5GpbwW5FLWyUYVYIFXcpp0L-INkuzUQVmzdTCZhqwX90mtHFbSMnYTG7dGMJzmkNEDdjLTbN6y7Zjv0Ek3j4--UfY7o8G5-r8dHj2Dp4RAXUJe4yLJmzMp7fmPWzh7_nlbPohW1wt-LVu-_wLEhZWuQ
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9tAEB7xqCIuKbQUQqENEpXgsI13Y3udQ4UQNCICIiSClNvWnt2VKqEkJIGqf41f11m_uATSSw5c7Z2V7f125hvvPAAOdMKFDbRmSNafkYWKWcIjjyVNJLaP5JJYTJtNyG436vdb10vwVOTCuLDKQiemiloP0f0jbwgehl7LlQhq2Dws4vqsfTy6Z66DlDtpLdppZBC5MH__kPs2-dE5o7X-JkT7Z-_0nOUdBhj6vpwyizzxpCFPCj1tkNzEEIWNyWvQ2HKV07QMtRbSxMSitCaAo5GWB4nnu8Ln2KR5l2FV-oFw4WRXXm9WTmYaXv-cPdS4KS8e8uiIGI30WP8lu_gS703tX_v9W_5y61DNWXf9JNsmG7BkBh-gcpXHFXyE6mmqMmkIul0w3oTbhTzOJ1gZDAdmG-pWog0i5IEmtsaxFctmbIkEBUlgrA79GvjFQinM66i7dh53akbAHI9Uur6qX4PvpdgoKyQyTyAsUKCKLFnS64pM3TzBqBTMaVRGj_5HdLeAkMp12UQ946cG--Vt0kLuaCkemOGDG0N6nuYQUQ22MpiWb9l0rDiIxM7rk3-FCsFSXXa6F59hjXipi-NjXOzCynT8YPbgHT5Of0_GX9J9Vodfi4bnP5IUX4k
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cervical+cancer&rft.jtitle=The+Lancet+%28British+edition%29&rft.au=Cohen%2C+Paul+A&rft.au=Jhingran%2C+Anjua&rft.au=Oaknin%2C+Ana&rft.au=Denny%2C+Lynette&rft.date=2019-01-12&rft.issn=1474-547X&rft.eissn=1474-547X&rft.volume=393&rft.issue=10167&rft.spage=169&rft_id=info:doi/10.1016%2FS0140-6736%2818%2932470-X&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0140-6736&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0140-6736&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0140-6736&client=summon